| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | EPS8L1 ECT2 DENND2B ARHGEF15 DOCK5 PLEKHG6 ARHGEF1 FGD5 RASGRP2 SOS1 | 1.87e-05 | 231 | 161 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | VAPA GPHN LIMA1 MAP4 SYNPO2L BRSK2 TRIOBP EPS8L1 MAST2 MAP10 KIF24 PDLIM5 GSK3A TTLL7 CEP350 SPATC1 HAUS8 MAP1S CLMN NAV3 MYO18B TNS1 | 7.44e-05 | 1099 | 161 | 22 | GO:0008092 |
| GeneOntologyCellularComponent | Golgi lumen | 2.14e-04 | 109 | 163 | 6 | GO:0005796 | |
| GeneOntologyCellularComponent | euchromatin | 2.49e-04 | 72 | 163 | 5 | GO:0000791 | |
| GeneOntologyCellularComponent | microtubule organizing center | MAP4 RBBP6 BRSK2 TRIOBP EYA3 MAP10 ECT2 KIF24 LUZP1 TTLL7 CEP350 SPATC1 HAUS8 PLEKHG6 NSFL1C MAP1S TP53 PDZD2 | 3.07e-04 | 919 | 163 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | RBBP6 BRSK2 TRIOBP EYA3 MAP10 ECT2 KIF24 LUZP1 CEP350 SPATC1 HAUS8 PLEKHG6 NSFL1C MAP1S TP53 PDZD2 | 3.54e-04 | 770 | 163 | 16 | GO:0005813 |
| GeneOntologyCellularComponent | nuclear body | ATXN2L HIF1A SETD1B INCENP SPN RBBP6 ZCCHC8 ICE2 ECT2 CACTIN DCANP1 CSF1 EIF4ENIF1 LMNA NHS MBD4 TP53 | 7.09e-04 | 903 | 163 | 17 | GO:0016604 |
| HumanPheno | Thin upper lip vermilion | HIVEP2 PPM1D TNRC6B SIM1 ARID1A PACS1 BMP2 IGF1R SETD5 STRADA ANKRD17 MYO18B CUX1 AFF4 | 9.10e-06 | 339 | 55 | 14 | HP:0000219 |
| HumanPheno | Thin lips | HIVEP2 PPM1D TNRC6B SIM1 ARID1A PACS1 BMP2 IGF1R SETD5 STRADA ANKRD17 MYO18B CUX1 AFF4 | 9.10e-06 | 339 | 55 | 14 | HP:0000213 |
| HumanPheno | Thin vermilion border | HIVEP2 PPM1D TNRC6B SIM1 ARID1A PACS1 BMP2 IGF1R LMNA SETD5 STRADA ANKRD17 MYO18B CUX1 AFF4 | 3.39e-05 | 433 | 55 | 15 | HP:0000233 |
| MousePheno | effusion | 1.54e-05 | 152 | 134 | 9 | MP:0021205 | |
| Domain | DUF1908 | 2.41e-06 | 4 | 159 | 3 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 2.41e-06 | 4 | 159 | 3 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 2.41e-06 | 4 | 159 | 3 | IPR023142 | |
| Domain | - | 2.41e-06 | 4 | 159 | 3 | 1.20.1480.20 | |
| Domain | PH_dom-like | SH2B3 DAB1 TRIOBP EPS8L1 ECT2 SH2B1 ARHGEF15 GAB2 PLEKHG6 ARHGEF1 PLCB3 FGD5 PLCB4 TNS1 SOS1 | 3.75e-06 | 426 | 159 | 15 | IPR011993 |
| Domain | RhoGEF | 2.45e-05 | 68 | 159 | 6 | SM00325 | |
| Domain | PDZ | 2.81e-05 | 141 | 159 | 8 | PF00595 | |
| Domain | RhoGEF | 2.90e-05 | 70 | 159 | 6 | PF00621 | |
| Domain | DH_2 | 2.90e-05 | 70 | 159 | 6 | PS50010 | |
| Domain | - | SH2B3 DAB1 TRIOBP ECT2 SH2B1 GAB2 PLEKHG6 ARHGEF1 PLCB3 FGD5 PLCB4 TNS1 SOS1 | 3.11e-05 | 391 | 159 | 13 | 2.30.29.30 |
| Domain | - | 3.14e-05 | 71 | 159 | 6 | 1.20.900.10 | |
| Domain | DH-domain | 3.14e-05 | 71 | 159 | 6 | IPR000219 | |
| Domain | PDZ | 3.98e-05 | 148 | 159 | 8 | SM00228 | |
| Domain | - | 4.37e-05 | 150 | 159 | 8 | 2.30.42.10 | |
| Domain | PDZ | 4.59e-05 | 151 | 159 | 8 | PS50106 | |
| Domain | PDZ | 4.81e-05 | 152 | 159 | 8 | IPR001478 | |
| Domain | DH_1 | 1.98e-04 | 63 | 159 | 5 | PS00741 | |
| Domain | PLC-beta_CS | 2.15e-04 | 3 | 159 | 2 | IPR009535 | |
| Domain | Phe_ZIP | 2.15e-04 | 3 | 159 | 2 | PF08916 | |
| Domain | Phe_ZIP | 2.15e-04 | 3 | 159 | 2 | IPR015012 | |
| Domain | SH2B | 2.15e-04 | 3 | 159 | 2 | IPR030523 | |
| Domain | DUF1154 | 2.15e-04 | 3 | 159 | 2 | PF06631 | |
| Domain | GDS_CDC24_CS | 3.30e-04 | 39 | 159 | 4 | IPR001331 | |
| Domain | PLC-beta | 4.27e-04 | 4 | 159 | 2 | IPR016280 | |
| Domain | C2_dom | 5.17e-04 | 164 | 159 | 7 | IPR000008 | |
| Domain | PH | 6.42e-04 | 278 | 159 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 6.58e-04 | 279 | 159 | 9 | PS50003 | |
| Domain | PH_domain | 6.75e-04 | 280 | 159 | 9 | IPR001849 | |
| Domain | WW | 6.78e-04 | 47 | 159 | 4 | PF00397 | |
| Domain | WW | 7.35e-04 | 48 | 159 | 4 | SM00456 | |
| Domain | WW_DOMAIN_1 | 9.26e-04 | 51 | 159 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 9.26e-04 | 51 | 159 | 4 | PS50020 | |
| Domain | SEA | 9.46e-04 | 23 | 159 | 3 | PS50024 | |
| Domain | SEA_dom | 9.46e-04 | 23 | 159 | 3 | IPR000082 | |
| Domain | WW_dom | 9.96e-04 | 52 | 159 | 4 | IPR001202 | |
| Domain | WxxW_domain | 1.06e-03 | 6 | 159 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.06e-03 | 6 | 159 | 2 | PF13330 | |
| Domain | CUT | 1.47e-03 | 7 | 159 | 2 | PS51042 | |
| Domain | CUT | 1.47e-03 | 7 | 159 | 2 | PF02376 | |
| Domain | CUT_dom | 1.47e-03 | 7 | 159 | 2 | IPR003350 | |
| Domain | CUT | 1.47e-03 | 7 | 159 | 2 | SM01109 | |
| Domain | PTEN_C2 | 1.95e-03 | 8 | 159 | 2 | PF10409 | |
| Domain | PTB | 1.95e-03 | 8 | 159 | 2 | IPR013625 | |
| Domain | PTEN_C2 | 1.95e-03 | 8 | 159 | 2 | SM01326 | |
| Domain | PTB | 1.95e-03 | 8 | 159 | 2 | PF08416 | |
| Domain | C2_TENSIN | 1.95e-03 | 8 | 159 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 1.95e-03 | 8 | 159 | 2 | IPR029023 | |
| Domain | Tensin_C2-dom | 1.95e-03 | 8 | 159 | 2 | IPR014020 | |
| Domain | PPASE_TENSIN | 2.49e-03 | 9 | 159 | 2 | PS51181 | |
| Domain | C8 | 4.49e-03 | 12 | 159 | 2 | PF08742 | |
| Domain | TIL | 4.49e-03 | 12 | 159 | 2 | PF01826 | |
| Domain | PTB | 4.75e-03 | 40 | 159 | 3 | SM00462 | |
| Domain | PTB/PI_dom | 5.09e-03 | 41 | 159 | 3 | IPR006020 | |
| Domain | Unchr_dom_Cys-rich | 5.28e-03 | 13 | 159 | 2 | IPR014853 | |
| Domain | C8 | 5.28e-03 | 13 | 159 | 2 | SM00832 | |
| Domain | TIL_dom | 6.13e-03 | 14 | 159 | 2 | IPR002919 | |
| Domain | SEA | 6.13e-03 | 14 | 159 | 2 | SM00200 | |
| Domain | - | 7.03e-03 | 15 | 159 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 7.03e-03 | 15 | 159 | 2 | SM00501 | |
| Domain | EF-hand_like | 7.03e-03 | 15 | 159 | 2 | PF09279 | |
| Domain | ARID_dom | 7.03e-03 | 15 | 159 | 2 | IPR001606 | |
| Domain | ARID | 7.03e-03 | 15 | 159 | 2 | PS51011 | |
| Domain | PI-PLC-Y | 7.03e-03 | 15 | 159 | 2 | PF00387 | |
| Domain | PLCYc | 7.03e-03 | 15 | 159 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 7.03e-03 | 15 | 159 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 7.03e-03 | 15 | 159 | 2 | PS50008 | |
| Domain | Glyco_hormone_CN | 7.03e-03 | 15 | 159 | 2 | IPR006208 | |
| Domain | ARID | 7.03e-03 | 15 | 159 | 2 | PF01388 | |
| Domain | Cys_knot | 7.03e-03 | 15 | 159 | 2 | PF00007 | |
| Domain | PI-PLC_fam | 7.03e-03 | 15 | 159 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 7.03e-03 | 15 | 159 | 2 | IPR015359 | |
| Domain | C2 | 7.39e-03 | 142 | 159 | 5 | PS50004 | |
| Domain | VWF_type-D | 7.99e-03 | 16 | 159 | 2 | IPR001846 | |
| Domain | VWFD | 7.99e-03 | 16 | 159 | 2 | PS51233 | |
| Domain | VWD | 7.99e-03 | 16 | 159 | 2 | SM00216 | |
| Domain | VWD | 7.99e-03 | 16 | 159 | 2 | PF00094 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.91e-09 | 16 | 123 | 6 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 4.47e-09 | 17 | 123 | 6 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.49e-08 | 23 | 123 | 6 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 7.79e-08 | 26 | 123 | 6 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.61e-05 | 62 | 123 | 6 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.75e-05 | 68 | 123 | 6 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.94e-05 | 21 | 123 | 4 | MM15706 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GPHN ATXN2L LIMA1 ITCH HIVEP2 MAP4 ZCCHC8 EXPH5 WWP2 BRSK2 MAST2 ECT2 DENND2B GSK3A LUZP1 GAB2 CEP350 USP31 HAUS8 WWC2 IGF1R MAST4 CLMN RPTOR ARHGEF1 EIF4B MAP3K9 FIP1L1 ANKRD17 NCOA7 NHS GIGYF2 BOD1L1 SIPA1L2 TP53 | 1.46e-22 | 861 | 166 | 35 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B ATXN2L EPRS1 LIMA1 ZEB1 MAP4 RBBP6 ZCCHC8 FNBP4 NUP214 GSK3A KANSL3 PACS1 SCAF1 CACTIN WWC2 NSFL1C LMNA MAP1S NFIC RPTOR EIF4B FIP1L1 ANKRD17 GIGYF2 PLCB3 ZMYM4 SOS1 | 7.81e-17 | 774 | 166 | 28 | 15302935 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC12A6 HIF1A ITCH HIVEP2 MAP4 ATXN7L1 WWP2 FNBP4 DAB1 TRIOBP TNRC6B ARID1A ZHX2 TTC3 DENND2B SH2B1 KANSL3 DOCK5 HIVEP3 PACS1 IGF1R SETD5 CLMN NFIC RPTOR ANKRD17 BOD1L1 PLCB4 IGSF9B QSER1 SPIDR ZMYM4 CUX1 AFF4 PDZD2 | 3.87e-15 | 1489 | 166 | 35 | 28611215 |
| Pubmed | GPHN ATXN2L EPRS1 LIMA1 MAP4 RBBP6 FNBP4 PPP1R13B TNRC6B ARID1A NCAPH PDLIM5 LUZP1 ARID3B GIGYF2 BOD1L1 QSER1 ZMYM4 CUX1 TP53 | 2.45e-12 | 549 | 166 | 20 | 38280479 | |
| Pubmed | NOL4 ITCH RBBP6 ATXN7L1 ZCCHC8 CECR2 ADNP2 TNRC6B REV3L PPFIA3 ARID1A MAST2 LUZP1 SCAF1 CACTIN EIF4ENIF1 SETD5 RPTOR FIP1L1 ANKRD17 SIPA1L2 ANAPC7 AFF4 TP53 SOS1 | 1.43e-10 | 1116 | 166 | 25 | 31753913 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.91e-10 | 18 | 166 | 6 | 18834073 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B ATXN2L EPRS1 INCENP MAP4 RBBP6 FNBP4 SRP72 NUP214 ARID1A LUZP1 ARID3B LMNA EIF4B FIP1L1 GIGYF2 BOD1L1 QSER1 MBD4 ZMYM4 CUX1 AFF4 TP53 | 2.04e-10 | 954 | 166 | 23 | 36373674 |
| Pubmed | HIVEP2 RBBP6 EXPH5 ADNP2 PPP1R13B NUP214 MUC12 GAB2 CEP350 POM121 ARHGEF1 NAV3 ANKRD17 GIGYF2 TNS1 CUX1 SOS1 | 2.20e-10 | 486 | 166 | 17 | 20936779 | |
| Pubmed | ATXN2L EPRS1 LIMA1 HIF1A ITCH MAP4 RBBP6 WWP2 TNRC6B SRP72 NUP214 MED13L ARID1A PDLIM5 GSK3A LUZP1 IGF1R NSFL1C LMNA EIF4B FIP1L1 ANKRD17 NHS CUX1 AFF4 | 1.40e-09 | 1247 | 166 | 25 | 27684187 | |
| Pubmed | 3.61e-09 | 49 | 166 | 7 | 31762063 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN ATXN2L EPRS1 LIMA1 MAP4 RBBP6 ZCCHC8 TNRC6B NUP214 NCAPH PDLIM5 FAM193A CLMN EIF4B ANKRD17 NCOA7 GIGYF2 BOD1L1 SIPA1L2 AFF4 TP53 | 4.56e-09 | 934 | 166 | 21 | 33916271 |
| Pubmed | GPHN SLC12A6 ATXN2L EPRS1 LIMA1 MAP4 BRSK2 SRP72 LRRTM1 PPFIA3 ARID1A DNAJC6 CCDC177 PDLIM5 LUZP1 USP31 PACS1 LMNA MAP1S LRIG1 CLMN RPTOR ARHGEF1 EIF4B SIPA1L2 TNS1 | 4.88e-09 | 1431 | 166 | 26 | 37142655 | |
| Pubmed | PDS5B SETD1B TNRC6B NUP214 MED13L ZHX2 DNAJC6 USP31 SETD5 NAV3 GIGYF2 BOD1L1 SIPA1L2 PDZD2 | 1.14e-08 | 407 | 166 | 14 | 12693553 | |
| Pubmed | EPRS1 ITCH HIVEP2 ZCCHC8 ADNP2 TRIOBP REV3L EYA3 MED13L ARID1A TTC3 SH2B1 PDLIM5 GSK3A CEP350 MAP1S NAV3 FIP1L1 MBD4 CCDC24 ZMYM4 CUX1 AFF4 SOS1 | 1.21e-08 | 1285 | 166 | 24 | 35914814 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L MAP4 ICE2 TRIOBP TNRC6B TTC3 PDLIM5 LUZP1 CEP350 HAUS8 FAM193A EIF4ENIF1 NSFL1C EIF4B FIP1L1 ANKRD17 GIGYF2 ANAPC7 | 1.37e-08 | 724 | 166 | 18 | 36232890 |
| Pubmed | VAPA NOL4 LIMA1 ZEB1 RBBP6 ATXN7L1 PPP1R13B TNRC6B SRP72 PROSER1 NUP214 EYA3 ARID1A ZHX2 ARID3B KANSL3 EIF4ENIF1 NFIC FIP1L1 ANKRD17 GIGYF2 QSER1 ZMYM4 CUX1 TP53 | 2.10e-08 | 1429 | 166 | 25 | 35140242 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | ATXN2L EPRS1 LIMA1 MAP4 NUP214 NCAPH LUZP1 EIF4ENIF1 EIF4B ANKRD17 GIGYF2 | 4.78e-08 | 256 | 166 | 11 | 33397691 |
| Pubmed | EXPH5 PPP1R13B TNRC6B ARID1A POM121 FAM193A EIF4ENIF1 FIP1L1 NHS GIGYF2 SIPA1L2 | 6.29e-08 | 263 | 166 | 11 | 34702444 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | VAPA ATXN2L LIMA1 MAP4 PPP1R13B NUP214 EPS8L1 PDLIM5 LUZP1 NSFL1C CLMN EIF4B NHS GIGYF2 PLCB3 | 1.01e-07 | 565 | 166 | 15 | 25468996 |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 26770020 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATXN2L SETD1B RBBP6 ZCCHC8 PPM1D PPP1R13B EYA3 ARID1A GSK3A LUZP1 KANSL3 RPTOR SIPA1L2 ZMYM4 TP53 | 1.69e-07 | 588 | 166 | 15 | 38580884 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GPHN REV3L RUNX1T1 NCAPH ECT2 SH2B1 TTLL7 ARID3B KANSL3 NFIC FIP1L1 ANKRD17 QSER1 SPIDR ANAPC7 ZMYM4 CUX1 TP53 | 1.71e-07 | 857 | 166 | 18 | 25609649 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | RBBP6 NUP214 MAGEE1 SH2B1 DOCK5 POM121 FAM193A EIF4ENIF1 LMNA MAP1S IGSF9B TP53 SOS1 | 1.72e-07 | 430 | 166 | 13 | 35044719 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MAP4 RBBP6 EPS8L1 MAST2 ECT2 SCAF1 LMNA MAP1S EIF4B FIP1L1 MYO18B ZMYM4 | 1.90e-07 | 361 | 166 | 12 | 26167880 |
| Pubmed | GPHN LIMA1 ZEB1 ITCH TRIOBP TNRC6B LRRTM1 PPFIA3 TTC3 DNAJC6 CCDC177 LUZP1 RPTOR ANKRD17 GIGYF2 QSER1 TNS1 CUX1 AFF4 | 1.98e-07 | 963 | 166 | 19 | 28671696 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | LIMA1 MAP4 ICE2 TNRC6B EYA3 ZHX2 LUZP1 ARID3B KANSL3 LMNA EIF4B ZMYM4 TP53 | 2.47e-07 | 444 | 166 | 13 | 34795231 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PDS5B NOL4 INCENP ADNP2 EYA3 ARID3B CACTIN NFIC BOD1L1 QSER1 MBD4 ANAPC7 ZMYM4 CUX1 AFF4 | 2.59e-07 | 608 | 166 | 15 | 36089195 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VAPA ONECUT2 EPRS1 HIF1A VAMP5 RBBP6 ZCCHC8 FNBP4 NUP214 ARID1A KANSL3 DOCK5 SCAF1 CACTIN LMNA NFIC FIP1L1 QSER1 MBD4 ANAPC7 ZMYM4 CUX1 | 2.62e-07 | 1294 | 166 | 22 | 30804502 |
| Pubmed | PDS5B ATXN2L EPRS1 MAP4 SRP72 EYA3 MED13L ARID1A ARID3B KANSL3 NSFL1C NFIC EIF4B FIP1L1 QSER1 ANAPC7 ZMYM4 CUX1 TP53 RASGRP2 | 3.53e-07 | 1103 | 166 | 20 | 34189442 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | VAPA GPHN LIMA1 PCARE ECT2 LUZP1 GAB2 ARID3B DOCK5 PACS1 HAUS8 POM121 EIF4ENIF1 SETD5 RPTOR GIGYF2 MINDY4 QSER1 MUC5AC ANAPC7 TP53 MAST3 | 3.71e-07 | 1321 | 166 | 22 | 27173435 |
| Pubmed | PDS5B RBBP6 ZCCHC8 CECR2 NUP214 ARID1A NCAPH LUZP1 ARID3B HAUS8 CACTIN BOD1L1 ZMYM4 | 4.60e-07 | 469 | 166 | 13 | 27634302 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | INCENP MUC16 KIF24 PDLIM5 DOCK5 DCANP1 FAM193A NFIC FGD5 IGSF9B MUC3A TNS1 MAST3 MUC20 | 4.75e-07 | 552 | 166 | 14 | 10737800 |
| Pubmed | VAPA ATXN2L ICE2 TNRC6B NUP214 PDLIM5 ARID3B CEP350 HAUS8 FAM193A EIF4ENIF1 NSFL1C CLMN FIP1L1 BOD1L1 QSER1 | 5.19e-07 | 733 | 166 | 16 | 34672954 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | VAPA GPHN PDS5B INCENP TRIOBP PROSER1 NUP214 ERGIC2 ARID1A ECT2 KIF24 CEP350 KANSL3 PACS1 HAUS8 MAP1S EIF4B IFFO2 ANAPC7 ZMYM4 | 7.23e-07 | 1155 | 166 | 20 | 20360068 |
| Pubmed | 7.82e-07 | 153 | 166 | 8 | 10718198 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PPP1R13B TNRC6B MAST2 PDLIM5 GSK3A LUZP1 CEP350 HAUS8 MAST4 EIF4ENIF1 NSFL1C EIF4B IFFO2 GIGYF2 MINDY4 SIPA1L2 TP53 | 7.90e-07 | 853 | 166 | 17 | 28718761 |
| Pubmed | TNRC6B GSK3A LUZP1 CEP350 FAM193A MAST4 EIF4ENIF1 NHS SIPA1L2 | 8.06e-07 | 209 | 166 | 9 | 36779422 | |
| Pubmed | 8.68e-07 | 107 | 166 | 7 | 30995489 | ||
| Pubmed | ATXN2L EPRS1 LIMA1 MAP4 RBBP6 ZCCHC8 LUZP1 LMNA FIP1L1 GIGYF2 | 8.83e-07 | 274 | 166 | 10 | 34244482 | |
| Pubmed | NOL4 ZEB1 ZCCHC8 TNRC6B NUP214 LUZP1 FAM193A EIF4ENIF1 ANKRD17 GIGYF2 ZMYM4 CUX1 | 8.95e-07 | 418 | 166 | 12 | 34709266 | |
| Pubmed | GPHN ATXN2L EPRS1 MAP4 RBBP6 ZCCHC8 WWP2 NCAPH ECT2 LMNA RPTOR FIP1L1 NHS | 1.00e-06 | 503 | 166 | 13 | 16964243 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 26468276 | ||
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 1.54e-06 | 226 | 166 | 9 | 25900982 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIVEP2 SETD1B SH2B3 NUP214 REV3L MED13L ARID1A MAST2 TTC3 KANSL3 HIVEP3 SCAF1 IGF1R EIF4ENIF1 MAP1S SETD5 RPTOR UNKL SIPA1L2 | 1.55e-06 | 1105 | 166 | 19 | 35748872 |
| Pubmed | LIMA1 ZCCHC8 PPP1R13B TNRC6B ARID1A MAST2 LUZP1 FAM193A EIF4ENIF1 MAP1S GIGYF2 SIPA1L2 | 1.75e-06 | 446 | 166 | 12 | 24255178 | |
| Pubmed | 1.83e-06 | 19 | 166 | 4 | 30449657 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | LIMA1 WBP1L FNBP4 TNRC6B MED13L ARID1A DNAJC6 KIF24 EIF4B PLCB4 SZRD1 CUX1 SOS1 | 2.02e-06 | 536 | 166 | 13 | 15840001 |
| Pubmed | LIMA1 WBP1L FNBP4 TNRC6B MED13L ARID1A DNAJC6 KIF24 EIF4B PLCB4 SZRD1 CUX1 SOS1 | 2.11e-06 | 538 | 166 | 13 | 10512203 | |
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 19110483 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.22e-06 | 123 | 166 | 7 | 26912792 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | ATXN2L ZCCHC8 TNRC6B NUP214 MAST2 TTC3 ECT2 PACS1 FAM193A NFIC ANKRD17 UNKL | 2.52e-06 | 462 | 166 | 12 | 31138677 |
| Pubmed | TNRC6B NUP214 PDLIM5 CEP350 EIF4ENIF1 ANKRD17 GIGYF2 QSER1 SIPA1L2 | 2.70e-06 | 242 | 166 | 9 | 34011540 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | VAPA ATXN2L SETD1B TNRC6B NUP214 CCDC177 FAM193A CLMN NAV3 PLCB3 IGSF9B MAST3 | 3.35e-06 | 475 | 166 | 12 | 31040226 |
| Pubmed | Transmembrane adaptor protein WBP1L regulates CXCR4 signalling and murine haematopoiesis. | 3.69e-06 | 7 | 166 | 3 | 31845480 | |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 4.54e-06 | 137 | 166 | 7 | 37039823 | |
| Pubmed | SLC12A6 ITCH SRP72 BCL3 MAST2 TTC3 ECT2 LMNA CLMN EIF4B MYO18B ZMYM4 | 5.30e-06 | 497 | 166 | 12 | 23414517 | |
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 6.10e-06 | 54 | 166 | 5 | 25631074 | |
| Pubmed | 6.18e-06 | 268 | 166 | 9 | 33640491 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | PDS5B ATXN2L RBBP6 ZCCHC8 PPM1D ARID1A NSFL1C NFIC FIP1L1 AFF4 | 6.19e-06 | 341 | 166 | 10 | 32971831 |
| Pubmed | 7.32e-06 | 56 | 166 | 5 | 30718289 | ||
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 7.45e-06 | 97 | 166 | 6 | 37151849 | |
| Pubmed | ATXN2L WWP2 TNRC6B MAGEE1 RUNX1T1 ZHX2 PDLIM5 CEP350 SCAF1 POM121 EIF4ENIF1 GRIP2 TP53 | 7.89e-06 | 608 | 166 | 13 | 16713569 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NOL4 ZEB1 HIVEP2 PROSER1 NUP214 ARID1A ZHX2 NFIC QSER1 ZMYM4 | 7.97e-06 | 351 | 166 | 10 | 38297188 |
| Pubmed | VAPA ATXN2L EPRS1 MAP4 ICE2 TNRC6B SRP72 NUP214 PDLIM5 NSFL1C EIF4B ANKRD17 GIGYF2 BOD1L1 | 8.48e-06 | 708 | 166 | 14 | 39231216 | |
| Pubmed | 8.78e-06 | 9 | 166 | 3 | 20810912 | ||
| Pubmed | 9.30e-06 | 282 | 166 | 9 | 23667531 | ||
| Pubmed | VAPA GPHN ATXN2L EPRS1 MAP4 BRSK2 TRIOBP TNRC6B PPFIA3 GSK3A NSFL1C LMNA MAP1S KCNF1 RPTOR EIF4B NAV3 SIPA1L2 | 9.42e-06 | 1139 | 166 | 18 | 36417873 | |
| Pubmed | VAPA ATXN2L EPRS1 MAP4 WWP2 FNBP4 DAB1 TNRC6B SRP72 PDLIM5 LUZP1 CEP350 KANSL3 SCAF1 CACTIN FIP1L1 ANKRD17 MUC5AC AFF4 TP53 | 9.47e-06 | 1371 | 166 | 20 | 36244648 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.07e-05 | 363 | 166 | 10 | 14691545 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.08e-05 | 218 | 166 | 8 | 33378226 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 PCARE BCL3 REV3L PPFIA3 ECT2 SPATC1 DOCK5 SCAF1 LMNA MAP3K9 BOD1L1 PLCB3 IGSF9B | 1.31e-05 | 736 | 166 | 14 | 29676528 |
| Pubmed | 1.71e-05 | 11 | 166 | 3 | 24429156 | ||
| Pubmed | EPRS1 MAP4 ITGA9 TTC3 PACS1 WWC2 SETD5 CLMN ARHGEF1 EIF4B MAP3K9 ANKRD17 BOD1L1 QSER1 TNS1 SZRD1 AFF4 | 1.86e-05 | 1084 | 166 | 17 | 11544199 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 21947346 | ||
| Pubmed | Aspp1 Preserves Hematopoietic Stem Cell Pool Integrity and Prevents Malignant Transformation. | 2.26e-05 | 2 | 166 | 2 | 26119234 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 15170665 | ||
| Pubmed | Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. | 2.26e-05 | 2 | 166 | 2 | 12124396 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 37146737 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31538203 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 2.26e-05 | 2 | 166 | 2 | 14988081 | |
| Pubmed | Nuclear Lamin A/C Expression Is a Key Determinant of Paclitaxel Sensitivity. | 2.26e-05 | 2 | 166 | 2 | 33972393 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 17621824 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22220206 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 24317696 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 30188093 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 2.26e-05 | 2 | 166 | 2 | 35776514 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 17236590 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 24327612 | ||
| Pubmed | Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis. | 2.26e-05 | 2 | 166 | 2 | 23256545 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 20404140 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 29307819 | ||
| Pubmed | IL-1β upregulates Muc5ac expression via NF-κB-induced HIF-1α in asthma. | 2.26e-05 | 2 | 166 | 2 | 29031476 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 35906707 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 21041409 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 17114052 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31030254 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25592037 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 16540890 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 17936922 | ||
| Interaction | SFN interactions | ATXN2L LIMA1 HIF1A ITCH MAP4 EXPH5 MAST2 DENND2B GSK3A LUZP1 GAB2 CEP350 USP31 HAUS8 WWC2 IGF1R MAST4 NSFL1C LMNA CLMN NFIC EIF4B ANKRD17 NHS SIPA1L2 TP53 | 7.26e-11 | 692 | 164 | 26 | int:SFN |
| Interaction | YWHAG interactions | VAPA GPHN ATXN2L LIMA1 ITCH HIVEP2 EXPH5 MAST2 DENND2B GSK3A LUZP1 GAB2 TTLL7 CEP350 USP31 PACS1 HAUS8 WWC2 IGF1R MAST4 LMNA CLMN RPTOR ARHGEF1 EIF4B MAP3K9 FIP1L1 ANKRD17 NHS GIGYF2 SLAIN1 BOD1L1 SIPA1L2 TP53 MAST3 | 8.77e-11 | 1248 | 164 | 35 | int:YWHAG |
| Interaction | YWHAH interactions | VAPA ATXN2L LIMA1 HIVEP2 ZCCHC8 EXPH5 MAST2 ECT2 DENND2B GSK3A LUZP1 GAB2 TTLL7 CEP350 USP31 PACS1 HAUS8 WWC2 MAST4 CLMN RPTOR EIF4B MAP3K9 ANKRD17 NCOA7 NHS GIGYF2 SLAIN1 BOD1L1 SIPA1L2 MAST3 | 1.18e-09 | 1102 | 164 | 31 | int:YWHAH |
| Interaction | YWHAE interactions | VAPA ATXN2L LIMA1 HIVEP2 SH2B3 EXPH5 WWP2 BRSK2 MAST2 TTC3 DENND2B GSK3A LUZP1 GAB2 TTLL7 ARID3B USP31 PACS1 WWC2 IGF1R MAST4 RPTOR EIF4B MAP3K9 ANKRD17 NHS GIGYF2 FGD5 MINDY4 SIPA1L2 TP53 MAST3 | 6.82e-09 | 1256 | 164 | 32 | int:YWHAE |
| Interaction | YWHAZ interactions | VAPA ATXN2L LIMA1 HIVEP2 SH2B3 EXPH5 WWP2 PPFIA3 ARID1A ZHX2 MAST2 ECT2 DENND2B LUZP1 GAB2 ARID3B USP31 PACS1 WWC2 IGF1R MAST4 LMNA RPTOR EIF4B MAP3K9 ANKRD17 NHS GIGYF2 SIPA1L2 TNS1 TP53 MAST3 | 2.18e-08 | 1319 | 164 | 32 | int:YWHAZ |
| Interaction | YWHAB interactions | VAPA ATXN2L LIMA1 ZCCHC8 PPM1D EXPH5 MAST2 ECT2 DENND2B PDLIM5 GSK3A LUZP1 GAB2 CEP350 USP31 WWC2 IGF1R MAST4 EIF4B MAP3K9 ANKRD17 NHS GIGYF2 SLAIN1 SIPA1L2 TP53 MAST3 | 5.07e-08 | 1014 | 164 | 27 | int:YWHAB |
| Interaction | YAP1 interactions | GPHN ATXN2L EPRS1 LIMA1 HIF1A ZEB1 ITCH MAP4 RBBP6 WWP2 FNBP4 TRIOBP TNRC6B ARID1A NCAPH PDLIM5 LUZP1 ARID3B WWC2 IGF1R LMNA EIF4B GIGYF2 BOD1L1 IGSF9B ZMYM4 CUX1 TP53 | 6.47e-08 | 1095 | 164 | 28 | int:YAP1 |
| Interaction | BAG2 interactions | SLC12A6 HIF1A EXPH5 WWP2 FNBP4 PPP1R13B BCL3 EYA3 DNAJC6 ECT2 PDLIM5 LUZP1 DOCK5 EIF4ENIF1 RPTOR SLAIN1 BOD1L1 MINDY4 QSER1 TP53 | 1.75e-07 | 622 | 164 | 20 | int:BAG2 |
| Interaction | YWHAQ interactions | VAPA ATXN2L LIMA1 ITCH HIVEP2 MAP4 EXPH5 WWP2 ZHX2 MAST2 DENND2B GSK3A LUZP1 GAB2 CEP350 USP31 WWC2 IGF1R MAST4 LMNA RPTOR EIF4B MAP3K9 ANKRD17 NHS FGD5 SIPA1L2 | 3.59e-07 | 1118 | 164 | 27 | int:YWHAQ |
| Interaction | NUP43 interactions | PDS5B SETD1B INCENP MAP4 RBBP6 TNRC6B NUP214 ARID1A ZHX2 KANSL3 SCAF1 CACTIN POM121 EIF4ENIF1 LMNA BOD1L1 ZMYM4 TP53 PDZD2 | 8.46e-07 | 625 | 164 | 19 | int:NUP43 |
| Interaction | CAMSAP2 interactions | LIMA1 KIF24 GSK3A LUZP1 CEP350 MAP1S NFIC GIGYF2 PLCB3 MAST3 | 1.27e-06 | 169 | 164 | 10 | int:CAMSAP2 |
| Interaction | FMR1 interactions | ATXN2L EPRS1 ITCH RBBP6 CECR2 WWP2 TNRC6B ECT2 GSK3A LUZP1 EIF4ENIF1 ANKRD17 GIGYF2 GRIP2 TNS1 CUX1 AFF4 | 1.88e-06 | 536 | 164 | 17 | int:FMR1 |
| Interaction | SMC5 interactions | PDS5B ATXN2L EPRS1 INCENP MAP4 RBBP6 FNBP4 SRP72 NUP214 REV3L ARID1A LUZP1 ARID3B LMNA EIF4B FIP1L1 GIGYF2 BOD1L1 QSER1 MBD4 ZMYM4 CUX1 AFF4 TP53 | 1.94e-06 | 1000 | 164 | 24 | int:SMC5 |
| Interaction | HDAC4 interactions | VAPA ATXN2L EPRS1 LIMA1 HIF1A SETD1B TNRC6B NUP214 REV3L PDLIM5 GAB2 FAM193A NSFL1C MAP1S CLMN NAV3 GIGYF2 PLCB3 IGSF9B MAST3 | 2.83e-06 | 744 | 164 | 20 | int:HDAC4 |
| Interaction | CDH1 interactions | VAPA MYF5 ATXN2L LIMA1 ZEB1 MAP4 PPP1R13B NUP214 EPS8L1 ECT2 PDLIM5 LUZP1 NSFL1C LMNA CLMN EIF4B NHS GIGYF2 PLCB3 ANAPC7 | 4.55e-06 | 768 | 164 | 20 | int:CDH1 |
| Interaction | KDM1A interactions | NOL4 ZEB1 ZCCHC8 PPM1D TNRC6B NUP214 BCL3 DNAJC6 ECT2 LUZP1 CEP350 FAM193A EIF4ENIF1 NSFL1C ANKRD17 GIGYF2 UNKL MBD4 ZMYM4 CUX1 TP53 PHF13 | 8.21e-06 | 941 | 164 | 22 | int:KDM1A |
| Interaction | WWTR1 interactions | GPHN ATXN2L LIMA1 ZEB1 PPP1R13B TNRC6B ARID1A NCAPH PDLIM5 LUZP1 ARID3B QSER1 CUX1 TP53 | 9.58e-06 | 422 | 164 | 14 | int:WWTR1 |
| Interaction | MAST3 interactions | 1.07e-05 | 129 | 164 | 8 | int:MAST3 | |
| Interaction | SOX2 interactions | ATXN2L EPRS1 LIMA1 ZEB1 ITCH ZCCHC8 WWP2 TRIOBP SRP72 PROSER1 NUP214 EPS8L1 MED13L ST7L ARID1A MAST2 TTC3 LUZP1 ARID3B NFIC NAV3 FIP1L1 ANKRD17 BOD1L1 QSER1 SIPA1L2 ANAPC7 CUX1 | 1.12e-05 | 1422 | 164 | 28 | int:SOX2 |
| Interaction | TERF2IP interactions | PDS5B ZEB1 INCENP RBBP6 ZCCHC8 EPS8L1 EYA3 ARID1A ECT2 KANSL3 CACTIN BOD1L1 QSER1 ZMYM4 CUX1 AFF4 | 1.18e-05 | 552 | 164 | 16 | int:TERF2IP |
| Interaction | AP2B1 interactions | VAPA LIMA1 ICE2 TNRC6B DNAJC6 ECT2 CEP350 POM121 FAM193A NSFL1C FGD5 AFF4 TP53 | 1.20e-05 | 373 | 164 | 13 | int:AP2B1 |
| Interaction | SYNE3 interactions | VAPA EXPH5 PPP1R13B TNRC6B PROSER1 NUP214 CEP350 HAUS8 FAM193A EIF4ENIF1 CLMN SLAIN1 SIPA1L2 TP53 | 1.69e-05 | 444 | 164 | 14 | int:SYNE3 |
| Interaction | SMAD3 interactions | ATXN2L HIF1A ZEB1 ITCH WWP2 NUP214 ARID1A PDLIM5 IGF1R EIF4ENIF1 LMNA NFIC EIF4B TP53 | 1.82e-05 | 447 | 164 | 14 | int:SMAD3 |
| Interaction | PHLPP1 interactions | ATXN2L EPRS1 LIMA1 MAP4 NUP214 ARID1A NCAPH LUZP1 EIF4ENIF1 EIF4B ANKRD17 GIGYF2 | 1.89e-05 | 333 | 164 | 12 | int:PHLPP1 |
| Interaction | KCTD13 interactions | GPHN SLC12A6 ATXN2L EPRS1 LIMA1 MAP4 BRSK2 SRP72 LRRTM1 PPFIA3 ARID1A DNAJC6 CCDC177 PDLIM5 LUZP1 USP31 PACS1 NSFL1C LMNA MAP1S LRIG1 CLMN RPTOR ARHGEF1 EIF4B SIPA1L2 TNS1 | 2.21e-05 | 1394 | 164 | 27 | int:KCTD13 |
| Interaction | NUP50 interactions | ZEB1 RBBP6 FNBP4 NUP214 ARID1A NCAPH ARID3B POM121 EIF4ENIF1 LMNA BOD1L1 CUX1 | 2.38e-05 | 341 | 164 | 12 | int:NUP50 |
| Interaction | TRIM36 interactions | 2.39e-05 | 144 | 164 | 8 | int:TRIM36 | |
| Interaction | DUSP16 interactions | EXPH5 TTC3 NCAPH LUZP1 CEP350 HAUS8 EIF4ENIF1 ARHGEF1 GIGYF2 SIPA1L2 | 2.53e-05 | 237 | 164 | 10 | int:DUSP16 |
| Interaction | MEN1 interactions | PDS5B ATXN2L EPRS1 SETD1B RBBP6 ZCCHC8 PPM1D FNBP4 ARID1A LUZP1 KANSL3 NSFL1C NFIC FIP1L1 ANKRD17 GIGYF2 BOD1L1 QSER1 ZMYM4 CUX1 AFF4 TP53 | 3.25e-05 | 1029 | 164 | 22 | int:MEN1 |
| Interaction | EIF4E2 interactions | LIMA1 ZCCHC8 TNRC6B GAB2 EIF4ENIF1 RPTOR ANKRD17 GIGYF2 TP53 MAST3 | 3.47e-05 | 246 | 164 | 10 | int:EIF4E2 |
| Interaction | H3-3A interactions | PDS5B EPRS1 NOL4 SETD1B INCENP PPM1D ADNP2 EYA3 ARID3B CACTIN NFIC BOD1L1 QSER1 MBD4 ANAPC7 ZMYM4 CUX1 AFF4 | 4.07e-05 | 749 | 164 | 18 | int:H3-3A |
| Interaction | NAA40 interactions | GPHN ATXN2L EPRS1 LIMA1 MAP4 RBBP6 ZCCHC8 TNRC6B NUP214 NCAPH PDLIM5 FAM193A CLMN EIF4B ANKRD17 NCOA7 GIGYF2 BOD1L1 SIPA1L2 AFF4 TP53 | 4.68e-05 | 978 | 164 | 21 | int:NAA40 |
| Interaction | G3BP1 interactions | PDS5B ATXN2L ZEB1 ITCH MAP4 PPM1D WWP2 TNRC6B NUP214 ECT2 PDLIM5 GSK3A LUZP1 EIF4ENIF1 LMNA EIF4B ANKRD17 GIGYF2 TP53 | 5.14e-05 | 835 | 164 | 19 | int:G3BP1 |
| Interaction | FOS interactions | LIMA1 HIF1A ZEB1 NR6A1 BCL3 ARID1A ARID3B LMNA NFIC ANKRD17 TP53 | 5.16e-05 | 312 | 164 | 11 | int:FOS |
| Interaction | RCOR1 interactions | NOL4 ZCCHC8 TNRC6B BCL3 NCAPH DNAJC6 LUZP1 FAM193A EIF4ENIF1 ANKRD17 GIGYF2 ZMYM4 CUX1 PHF13 | 5.43e-05 | 494 | 164 | 14 | int:RCOR1 |
| Interaction | MAST4 interactions | 5.50e-05 | 26 | 164 | 4 | int:MAST4 | |
| Interaction | H3C3 interactions | PDS5B NOL4 INCENP ADNP2 EYA3 ARID3B CACTIN BOD1L1 QSER1 MBD4 ANAPC7 ZMYM4 CUX1 AFF4 | 5.54e-05 | 495 | 164 | 14 | int:H3C3 |
| Interaction | PABPC1 interactions | ATXN2L EPRS1 ZEB1 ITCH MAP4 WWP2 TNRC6B SRP72 NCAPH ECT2 GSK3A RPTOR EIF4B GIGYF2 UNKL FGD5 TP53 | 5.81e-05 | 699 | 164 | 17 | int:PABPC1 |
| Interaction | GIGYF2 interactions | ATXN2L LIMA1 ZCCHC8 WWP2 TNRC6B ECT2 ANKRD17 GIGYF2 TP53 MAST3 | 6.09e-05 | 263 | 164 | 10 | int:GIGYF2 |
| Interaction | TLE3 interactions | HIVEP2 RBBP6 CECR2 PROSER1 EYA3 ARID1A CACTIN POM121 FAM193A NFIC CUX1 TP53 | 6.15e-05 | 376 | 164 | 12 | int:TLE3 |
| Interaction | LATS1 interactions | ITCH WWP2 PPP1R13B TNRC6B MAST2 CEP350 WWC2 FAM193A LMNA EIF4B FIP1L1 SIPA1L2 TP53 | 6.64e-05 | 440 | 164 | 13 | int:LATS1 |
| Interaction | ZC3H7A interactions | ATXN2L TNRC6B TTC3 PDLIM5 FAM193A EIF4ENIF1 ANKRD17 GIGYF2 TP53 | 6.87e-05 | 215 | 164 | 9 | int:ZC3H7A |
| Interaction | SRPK2 interactions | MAP4 RBBP6 WWP2 SRP72 EPS8L1 MAST2 ECT2 GSK3A SCAF1 CACTIN LMNA MAP1S EIF4B FIP1L1 UNKL MYO18B ZMYM4 | 7.94e-05 | 717 | 164 | 17 | int:SRPK2 |
| Interaction | CEP135 interactions | PPP1R13B TNRC6B SRP72 ECT2 LUZP1 CEP350 HAUS8 SIPA1L2 ZMYM4 TP53 | 8.06e-05 | 272 | 164 | 10 | int:CEP135 |
| Interaction | GSK3B interactions | HIF1A MAP4 TRIOBP TNRC6B SRP72 BCL3 RUNX1T1 GSK3A LUZP1 CEP350 FAM193A MAST4 EIF4ENIF1 NSFL1C LMNA NHS SIPA1L2 MUC5AC TP53 | 8.58e-05 | 868 | 164 | 19 | int:GSK3B |
| Interaction | MARF1 interactions | 8.61e-05 | 128 | 164 | 7 | int:MARF1 | |
| Interaction | NXF1 interactions | VAPA EPRS1 LIMA1 WWP2 FNBP4 ADNP2 TNRC6B NUP214 ARID1A KIF24 ATP10D ARID3B CEP350 IFNGR1 CACTIN POM121 LMNA SETD5 RPTOR SLAIN1 PLCB3 MBD4 ZMYM4 SZRD1 TP53 | 8.96e-05 | 1345 | 164 | 25 | int:NXF1 |
| Interaction | SIPA1L1 interactions | 9.15e-05 | 174 | 164 | 8 | int:SIPA1L1 | |
| Interaction | EIF3B interactions | VAPA WWP2 SRP72 NCAPH CEP350 EIF4ENIF1 RPTOR EIF4B FGD5 MINDY4 TP53 | 1.03e-04 | 337 | 164 | 11 | int:EIF3B |
| Interaction | NFIX interactions | 1.04e-04 | 227 | 164 | 9 | int:NFIX | |
| Interaction | WBP1L interactions | 1.10e-04 | 12 | 164 | 3 | int:WBP1L | |
| Interaction | ZFP36 interactions | PPP1R13B TNRC6B NUP214 RUNX1T1 FAM193A EIF4ENIF1 ANKRD17 GIGYF2 | 1.20e-04 | 181 | 164 | 8 | int:ZFP36 |
| Interaction | PPP1CB interactions | LIMA1 MAP4 WWP2 TRIOBP PPP1R13B ECT2 DENND2B GSK3A LUZP1 PACS1 RPTOR EIF4B FGD5 | 1.26e-04 | 469 | 164 | 13 | int:PPP1CB |
| Interaction | SSX2IP interactions | PPP1R13B TNRC6B PDLIM5 GSK3A LUZP1 CEP350 HAUS8 EIF4ENIF1 SIPA1L2 TP53 | 1.29e-04 | 288 | 164 | 10 | int:SSX2IP |
| Interaction | LATS2 interactions | HIF1A PPP1R13B TNRC6B NUP214 WWC2 EIF4ENIF1 NFIC SIPA1L2 ANAPC7 TP53 | 1.33e-04 | 289 | 164 | 10 | int:LATS2 |
| Interaction | MET interactions | 1.36e-04 | 290 | 164 | 10 | int:MET | |
| Interaction | VASP interactions | GPHN HIF1A WWP2 PPP1R13B TNRC6B PCARE CEP350 NHS SIPA1L2 TP53 | 1.52e-04 | 294 | 164 | 10 | int:VASP |
| Interaction | SOX15 interactions | 1.58e-04 | 141 | 164 | 7 | int:SOX15 | |
| Interaction | CEP128 interactions | PPP1R13B TNRC6B SRP72 PDLIM5 LUZP1 CEP350 HAUS8 EIF4ENIF1 SIPA1L2 TP53 | 1.66e-04 | 297 | 164 | 10 | int:CEP128 |
| Interaction | DENND1A interactions | 1.77e-04 | 101 | 164 | 6 | int:DENND1A | |
| Interaction | NIN interactions | PPP1R13B TNRC6B GSK3A LUZP1 CEP350 HAUS8 EIF4ENIF1 IFFO2 GIGYF2 SIPA1L2 TP53 | 1.78e-04 | 359 | 164 | 11 | int:NIN |
| Interaction | NUP35 interactions | TNRC6B NUP214 ARID1A HIVEP3 POM121 EIF4ENIF1 LMNA NFIC GLRA2 ANKRD17 QSER1 PDZD2 | 1.90e-04 | 424 | 164 | 12 | int:NUP35 |
| Interaction | NCOA1 interactions | 1.96e-04 | 146 | 164 | 7 | int:NCOA1 | |
| Interaction | RNF43 interactions | EXPH5 PPP1R13B TNRC6B ARID1A POM121 FAM193A EIF4ENIF1 FIP1L1 NHS GIGYF2 SIPA1L2 TP53 | 2.02e-04 | 427 | 164 | 12 | int:RNF43 |
| Interaction | CTNNB1 interactions | ATXN2L HIF1A SPN WWP2 PPP1R13B NUP214 BCL3 NCAPH ECT2 PDLIM5 GSK3A IGF1R FAM193A NSFL1C LMNA CLMN NHS SIPA1L2 CUX1 TP53 | 2.10e-04 | 1009 | 164 | 20 | int:CTNNB1 |
| Interaction | LIMA1 interactions | LIMA1 ZCCHC8 FNDC4 ECT2 LUZP1 GAB2 PLEKHG6 RPTOR GIGYF2 FGD5 TP53 MAST3 | 2.11e-04 | 429 | 164 | 12 | int:LIMA1 |
| Interaction | BICD1 interactions | TNRC6B PDLIM5 GSK3A LUZP1 EIF4ENIF1 GIGYF2 MINDY4 SIPA1L2 TP53 | 2.15e-04 | 250 | 164 | 9 | int:BICD1 |
| Interaction | DDX11 interactions | 2.31e-04 | 68 | 164 | 5 | int:DDX11 | |
| Interaction | FEV interactions | 2.64e-04 | 203 | 164 | 8 | int:FEV | |
| Interaction | HDAC1 interactions | HIF1A ZEB1 ZCCHC8 WWP2 TNRC6B NUP214 BCL3 RUNX1T1 ARID1A ZHX2 NCAPH DNAJC6 PDLIM5 GSK3A LUZP1 EIF4ENIF1 ANKRD17 GIGYF2 MBD4 CUX1 TP53 | 2.66e-04 | 1108 | 164 | 21 | int:HDAC1 |
| Interaction | KCNA3 interactions | VAPA ATXN2L EPRS1 MAP4 RBBP6 EXPH5 ICE2 TNRC6B SRP72 NUP214 PDLIM5 LUZP1 NSFL1C RPTOR EIF4B ANKRD17 GIGYF2 BOD1L1 | 2.69e-04 | 871 | 164 | 18 | int:KCNA3 |
| Interaction | CAV1 interactions | VAPA SLC12A6 LIMA1 ITCH WWP2 FNDC4 ECT2 GSK3A IFNGR1 USP31 IGF1R LMNA SLC5A6 NCOA7 DANCR CUX1 | 2.87e-04 | 724 | 164 | 16 | int:CAV1 |
| Interaction | MAPRE1 interactions | LIMA1 PPP1R13B NUP214 BCL3 DNAJC6 LUZP1 CEP350 MAST4 MAP1S EIF4B NAV3 GIGYF2 SLAIN1 | 3.07e-04 | 514 | 164 | 13 | int:MAPRE1 |
| Interaction | GLDC interactions | ATXN2L EPRS1 LIMA1 MAP4 RBBP6 ZCCHC8 LUZP1 LMNA FIP1L1 GIGYF2 | 3.09e-04 | 321 | 164 | 10 | int:GLDC |
| Interaction | H2BC13 interactions | 3.31e-04 | 210 | 164 | 8 | int:H2BC13 | |
| Interaction | KPNA2 interactions | ITCH PPM1D WWP2 NCAPH ECT2 GSK3A POM121 EIF4ENIF1 LMNA RPTOR BOD1L1 FGD5 TP53 | 3.36e-04 | 519 | 164 | 13 | int:KPNA2 |
| Interaction | TOP3B interactions | EPRS1 LIMA1 HIVEP2 SETD1B SH2B3 TNRC6B SRP72 NUP214 REV3L MED13L ARID1A MAST2 TTC3 KANSL3 HIVEP3 SCAF1 IGF1R EIF4ENIF1 MAP1S SETD5 RPTOR ANKRD17 UNKL SIPA1L2 TP53 | 3.52e-04 | 1470 | 164 | 25 | int:TOP3B |
| Interaction | GSN interactions | 3.53e-04 | 212 | 164 | 8 | int:GSN | |
| Interaction | APC interactions | EXPH5 PPP1R13B NUP214 MAP10 GSK3A POM121 NAV3 ANKRD17 GIGYF2 MBD4 TP53 | 3.54e-04 | 389 | 164 | 11 | int:APC |
| Interaction | ARSH interactions | 3.91e-04 | 4 | 164 | 2 | int:ARSH | |
| Interaction | ZSWIM9 interactions | 3.95e-04 | 18 | 164 | 3 | int:ZSWIM9 | |
| Interaction | HNF4A interactions | 4.32e-04 | 275 | 164 | 9 | int:HNF4A | |
| Interaction | YBX1 interactions | EPRS1 HIF1A ZEB1 ITCH RBBP6 SRP72 ECT2 GSK3A LMNA RPTOR EIF4B GIGYF2 DANCR FGD5 MBD4 TP53 | 4.35e-04 | 752 | 164 | 16 | int:YBX1 |
| Interaction | HAPSTR1 interactions | PDS5B ATXN2L EPRS1 LIMA1 SETD1B RBBP6 PPM1D SRP72 PROSER1 NUP214 MED13L ARID1A RPTOR ANAPC7 ZMYM4 TP53 SOS1 | 4.38e-04 | 829 | 164 | 17 | int:HAPSTR1 |
| Interaction | FXR1 interactions | ATXN2L CECR2 WWP2 TRIOBP TNRC6B SRP72 PPFIA3 TTC3 GSK3A LUZP1 EIF4ENIF1 ANKRD17 GIGYF2 GRIP2 TP53 | 4.48e-04 | 679 | 164 | 15 | int:FXR1 |
| Interaction | CPSF7 interactions | ATXN2L ITCH WWP2 RUNX1T1 ECT2 EIF4ENIF1 FIP1L1 SLAIN1 UNKL TP53 | 4.63e-04 | 338 | 164 | 10 | int:CPSF7 |
| Interaction | TNRC6A interactions | TNRC6B ARID1A GSK3A FAM193A EIF4ENIF1 ANKRD17 GIGYF2 ANAPC7 AFF4 | 4.93e-04 | 280 | 164 | 9 | int:TNRC6A |
| Interaction | CEBPA interactions | PDS5B ATXN2L EPRS1 HIF1A ITCH MAP4 SRP72 EYA3 MED13L ARID1A ARID3B KANSL3 NSFL1C NFIC EIF4B FIP1L1 QSER1 ANAPC7 ZMYM4 CUX1 TP53 RASGRP2 | 4.94e-04 | 1245 | 164 | 22 | int:CEBPA |
| Interaction | EGR2 interactions | 5.10e-04 | 171 | 164 | 7 | int:EGR2 | |
| Interaction | EIF3K interactions | 5.10e-04 | 171 | 164 | 7 | int:EIF3K | |
| Interaction | PPM1H interactions | 5.14e-04 | 123 | 164 | 6 | int:PPM1H | |
| Interaction | EIF3H interactions | 5.18e-04 | 282 | 164 | 9 | int:EIF3H | |
| Interaction | FOXE1 interactions | 5.23e-04 | 81 | 164 | 5 | int:FOXE1 | |
| Interaction | RPGRIP1L interactions | 5.24e-04 | 225 | 164 | 8 | int:RPGRIP1L | |
| Interaction | LRFN1 interactions | 5.36e-04 | 124 | 164 | 6 | int:LRFN1 | |
| Interaction | DYRK2 interactions | 5.47e-04 | 173 | 164 | 7 | int:DYRK2 | |
| Interaction | NUP155 interactions | VAPA WWP2 TNRC6B NUP214 ERGIC2 ECT2 IGF1R POM121 LMNA CLMN SLAIN1 TP53 | 5.48e-04 | 477 | 164 | 12 | int:NUP155 |
| Interaction | KLF3 interactions | 5.72e-04 | 228 | 164 | 8 | int:KLF3 | |
| Interaction | TLX1 interactions | 5.86e-04 | 175 | 164 | 7 | int:TLX1 | |
| Interaction | MAPRE3 interactions | 6.05e-04 | 230 | 164 | 8 | int:MAPRE3 | |
| GeneFamily | CD molecules|Mucins | 1.78e-09 | 21 | 106 | 6 | 648 | |
| GeneFamily | PDZ domain containing | 3.12e-06 | 152 | 106 | 8 | 1220 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.24e-05 | 66 | 106 | 5 | 722 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.47e-05 | 15 | 106 | 3 | 529 | |
| GeneFamily | C2 and WW domain containing | 2.03e-04 | 4 | 106 | 2 | 838 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.12e-04 | 206 | 106 | 7 | 682 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 9.32e-04 | 8 | 106 | 2 | 837 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 1.19e-03 | 9 | 106 | 2 | 527 | |
| GeneFamily | AT-rich interaction domain containing | 3.40e-03 | 15 | 106 | 2 | 418 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 5.46e-03 | 19 | 106 | 2 | 832 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B HIF1A ZEB1 ITCH HIVEP2 REV3L MED13L ZHX2 MAST2 DENND2B PDLIM5 CEP350 IGF1R FAM193A LRIG1 NAV3 ANKRD17 GIGYF2 PLCB4 SPIDR ZMYM4 CUX1 SOS1 | 5.41e-09 | 856 | 166 | 23 | M4500 |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 1.19e-06 | 166 | 166 | 9 | M7009 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | SLC12A6 ZEB1 RBBP6 PPM1D WWP2 FNBP4 ADNP2 ARID3B IFNGR1 IGF1R POM121 LMNA GIGYF2 SLAIN1 BOD1L1 AFF4 | 7.25e-06 | 680 | 166 | 16 | M41089 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PDS5B ATXN2L ZEB1 HIVEP2 SH2B3 SPN RBBP6 FNBP4 TNRC6B EVI2B REV3L IGFLR1 ARID1A LUZP1 CEP350 HIVEP3 PACS1 CSF1 SETD5 ARHGEF1 EIF4B BOD1L1 MAST3 RASGRP2 SOS1 | 8.14e-06 | 1492 | 166 | 25 | M40023 |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP | 9.44e-06 | 162 | 166 | 8 | M7005 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.08e-05 | 165 | 166 | 8 | M9105 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | ATXN2L RBBP6 FNBP4 NUP214 EYA3 HAUS8 SCAF1 CACTIN LMNA SETD5 GRIP2 | 1.11e-05 | 338 | 166 | 11 | M17094 |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN | 1.23e-05 | 168 | 166 | 8 | M7007 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 1.29e-05 | 169 | 166 | 8 | M39230 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 1.32e-05 | 48 | 166 | 5 | M10253 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 1.32e-05 | 48 | 166 | 5 | MM1088 | |
| Coexpression | GCNP_SHH_UP_EARLY.V1_UP | 1.59e-05 | 174 | 166 | 8 | M2639 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 1.70e-05 | 85 | 166 | 6 | M10575 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN | 1.95e-05 | 179 | 166 | 8 | M6689 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 1.99e-05 | 295 | 166 | 10 | M39121 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | NOL4 BRSK2 REV3L MED13L RUNX1T1 TTC3 DNAJC6 TTLL7 HIVEP3 PACS1 MAST4 GLRA2 NAV3 MAP3K9 NCOA7 BOD1L1 CACNG4 PLCB4 IGSF9B GRIP2 | 2.46e-05 | 1106 | 166 | 20 | M39071 |
| Coexpression | ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP | 2.57e-05 | 186 | 166 | 8 | M3019 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SLC12A6 HIVEP2 SH2B3 VAMP5 RBBP6 ATXN7L1 PPP1R13B ERGIC2 ITGA9 DENND2B ARHGEF15 GAB2 TTLL7 DOCK5 WWC2 MAST4 FGD5 | 3.19e-05 | 854 | 166 | 17 | M1533 |
| Coexpression | GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP | 3.87e-05 | 197 | 166 | 8 | M3133 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP | 4.01e-05 | 198 | 166 | 8 | M4293 | |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_UP | 4.01e-05 | 198 | 166 | 8 | M3116 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP | 4.30e-05 | 200 | 166 | 8 | M5973 | |
| Coexpression | GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP | 4.30e-05 | 200 | 166 | 8 | M9397 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN | 4.30e-05 | 200 | 166 | 8 | M9733 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN | 4.30e-05 | 200 | 166 | 8 | M9925 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 4.30e-05 | 200 | 166 | 8 | M6477 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 4.30e-05 | 200 | 166 | 8 | M7839 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | VAPA LIMA1 ADNP2 TRIOBP TNRC6B DENND2B EIF4B GIGYF2 SIPA1L2 TP53 PHF13 PDZD2 | 4.56e-05 | 467 | 166 | 12 | M1347 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SLC12A6 HIVEP2 SH2B3 VAMP5 RBBP6 ATXN7L1 PPP1R13B ERGIC2 ITGA9 DENND2B ARHGEF15 GAB2 TTLL7 DOCK5 WWC2 MAST4 FGD5 | 5.19e-05 | 888 | 166 | 17 | MM1018 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | VAPA LIMA1 ADNP2 TRIOBP TNRC6B DENND2B EIF4B GIGYF2 SIPA1L2 TP53 PHF13 PDZD2 | 6.41e-05 | 484 | 166 | 12 | MM999 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | ITCH HIVEP2 FNBP4 ADNP2 MED13L ZHX2 ARID3B BMP2 IGF1R MAP1S SETD5 MAP3K9 CUX1 AFF4 PDZD2 SOS1 | 7.17e-05 | 822 | 166 | 16 | M6782 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN | 8.06e-05 | 162 | 166 | 7 | M7002 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 8.67e-05 | 221 | 166 | 8 | M39222 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP | 1.01e-04 | 168 | 166 | 7 | M8890 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | HIF1A ZEB1 ITCH SETD1B RBBP6 BCL3 ARID3B IGF1R UNKL MBD4 AFF4 | 1.03e-04 | 432 | 166 | 11 | M41149 |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | 1.04e-04 | 227 | 166 | 8 | M18441 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | EPRS1 HIVEP2 EXPH5 RUNX1T1 TTC3 DNAJC6 TTLL7 IGF1R MAST4 NFIC EIF4B GIGYF2 PLCB4 SIPA1L2 TNS1 AFF4 PDZD2 | 1.12e-04 | 946 | 166 | 17 | M39169 |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | 1.13e-04 | 171 | 166 | 7 | M8820 | |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 1.26e-04 | 174 | 166 | 7 | M6877 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.32e-04 | 300 | 166 | 9 | M8702 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | INCENP VAMP5 WBP1L TRIOBP LRRTM1 NCAPH ECT2 DOCK5 PACS1 HAUS8 LRIG1 CLMN STRADA NAV3 SIPA1L2 MBD4 TNS1 XKR5 | 1.32e-04 | 1054 | 166 | 18 | M45798 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.53e-04 | 240 | 166 | 8 | M39236 | |
| Coexpression | LIAO_METASTASIS | ATXN2L MAP4 CECR2 BCAS4 DNAJC6 ECT2 SH2B1 LUZP1 TTLL7 ARHGEF1 NAV3 SZRD1 | 1.79e-04 | 540 | 166 | 12 | M13809 |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 1.81e-04 | 313 | 166 | 9 | M39128 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | ARID1A MAST2 DNAJC6 LUZP1 TTLL7 HIVEP3 FAM193A SETD5 BOD1L1 FGD5 C1orf216 FAM149B1 ZMYM4 SZRD1 PHF13 | 2.00e-04 | 807 | 166 | 15 | M14594 |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP | 2.10e-04 | 189 | 166 | 7 | M9978 | |
| Coexpression | GSE45365_NK_CELL_VS_CD8_TCELL_DN | 2.24e-04 | 191 | 166 | 7 | M10008 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | ATXN2L ZEB1 RBBP6 FNBP4 LUZP1 IGF1R NSFL1C SLC5A6 GIGYF2 MBD4 AFF4 | 2.30e-04 | 474 | 166 | 11 | M40991 |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN | 2.38e-04 | 193 | 166 | 7 | M6903 | |
| Coexpression | GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP | 2.44e-04 | 137 | 166 | 6 | M415 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 2.46e-04 | 194 | 166 | 7 | M7313 | |
| Coexpression | GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP | 2.46e-04 | 194 | 166 | 7 | M5136 | |
| Coexpression | GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP | 2.54e-04 | 195 | 166 | 7 | M8140 | |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 2.54e-04 | 195 | 166 | 7 | M7310 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN | 2.70e-04 | 197 | 166 | 7 | M3472 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 2.78e-04 | 198 | 166 | 7 | M8624 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP | 2.87e-04 | 199 | 166 | 7 | M4521 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN | 2.87e-04 | 199 | 166 | 7 | M6632 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN | 2.96e-04 | 200 | 166 | 7 | M5986 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 2.96e-04 | 200 | 166 | 7 | M302 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 2.96e-04 | 200 | 166 | 7 | M5851 | |
| Coexpression | GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN | 2.96e-04 | 200 | 166 | 7 | M3513 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP | 2.96e-04 | 200 | 166 | 7 | M3404 | |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TEFF_UP | 2.96e-04 | 200 | 166 | 7 | M3423 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 2.96e-04 | 200 | 166 | 7 | M8500 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN | 2.96e-04 | 200 | 166 | 7 | M3929 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 2.96e-04 | 200 | 166 | 7 | M7502 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN | 2.96e-04 | 200 | 166 | 7 | M6000 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP | 2.96e-04 | 200 | 166 | 7 | M6352 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 2.96e-04 | 200 | 166 | 7 | M5282 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN | 2.96e-04 | 200 | 166 | 7 | M5271 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | 2.96e-04 | 200 | 166 | 7 | M6514 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP | 2.96e-04 | 200 | 166 | 7 | M6832 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP | 2.96e-04 | 200 | 166 | 7 | M6836 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 3.43e-04 | 417 | 166 | 10 | M39224 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 3.49e-04 | 418 | 166 | 10 | M12676 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_ILC2_CELL | 3.98e-04 | 150 | 166 | 6 | M45769 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 4.73e-04 | 155 | 166 | 6 | M39246 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 4.77e-04 | 435 | 166 | 10 | MM1221 | |
| Coexpression | KIM_WT1_TARGETS_UP | 4.83e-04 | 217 | 166 | 7 | M9128 | |
| Coexpression | AMIT_EGF_RESPONSE_240_HELA | 5.38e-04 | 59 | 166 | 4 | M7714 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | PDS5B SH2B3 INCENP ZCCHC8 DAB1 SRP72 PROSER1 NCAPH BCAS4 ECT2 USP31 BMP2 HAUS8 NSFL1C SLC5A6 SLAIN1 MBD4 TNS1 CUX1 | 5.50e-04 | 1290 | 166 | 19 | M80 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | VAPA RBBP6 DAB1 NUP214 REV3L CEP350 USP31 FAM193A NAV3 GIGYF2 CUX1 | 7.12e-07 | 209 | 164 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 1.04e-06 | 69 | 164 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | VAPA PDS5B NOL4 HIF1A MAP4 RBBP6 BRSK2 DAB1 DRGX ERGIC2 REV3L RUNX1T1 TTC3 DNAJC6 PDLIM5 CEP350 USP31 SETD5 GLRA2 PLCB4 CUX1 | 1.42e-06 | 818 | 164 | 21 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_200 | 3.68e-06 | 54 | 164 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_200_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | GPHN MAP4 RBBP6 PPM1D ICE2 CECR2 TNRC6B REV3L MAST2 LUZP1 GAB2 FAM193A MAST4 EIF4ENIF1 FAM149B1 SIPA1L2 ZMYM4 CUX1 AFF4 | 9.91e-06 | 780 | 164 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | VAPA CECR2 WWP2 FNBP4 DAB1 NUP214 ERGIC2 SIM1 REV3L PDLIM5 CEP350 FAM193A RPTOR EIF4B CRB3 NCOA7 GIGYF2 FGD5 CUX1 | 1.29e-05 | 795 | 164 | 19 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_200 | 1.37e-05 | 40 | 164 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOL4 ZEB1 INCENP RBBP6 PPM1D ICE2 CECR2 DAB1 SIM1 REV3L ARID1A NCAPH KIF24 LUZP1 ARID3B CEP350 FAM193A SETD5 FIP1L1 DANCR BOD1L1 CACNG4 QSER1 FAM149B1 XKR5 CUX1 SOS1 | 1.97e-05 | 1459 | 164 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K1 | LIMA1 HIVEP2 SH2B3 BCL3 DENND2B ARHGEF15 ATP10D GAB2 IFNGR1 HIVEP3 CSF1 LMNA ECSCR NFIC IFFO2 PLCB3 FGD5 SIPA1L2 MAST3 | 3.25e-05 | 850 | 164 | 19 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ZEB1 INCENP RBBP6 PPM1D ICE2 DAB1 REV3L ARID1A NCAPH KIF24 LUZP1 ARID3B CEP350 FAM193A SETD5 FIP1L1 DANCR BOD1L1 CACNG4 QSER1 FAM149B1 XKR5 CUX1 SOS1 | 3.69e-05 | 1257 | 164 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 4.02e-05 | 163 | 164 | 8 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | VAPA FNBP4 DAB1 NUP214 ERGIC2 SIM1 REV3L CEP350 FAM193A RPTOR EIF4B CUX1 | 4.04e-05 | 379 | 164 | 12 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 4.58e-05 | 166 | 164 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#1_top-relative-expression-ranked_500 | 5.01e-05 | 52 | 164 | 5 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | VAPA PDS5B HIF1A DAB1 REV3L TTC3 PDLIM5 CEP350 USP31 SETD5 CUX1 | 5.37e-05 | 330 | 164 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | LIMA1 ZEB1 HIVEP2 SH2B3 ATXN7L1 ITGA9 ARHGEF15 ATP10D LUZP1 IFNGR1 BMP2 CSF1 ECSCR NFIC PLCB3 FGD5 TNS1 RASGRP2 | 1.45e-04 | 872 | 164 | 18 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 1.61e-04 | 149 | 164 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_200 | 2.14e-04 | 156 | 164 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_200 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.23e-04 | 157 | 164 | 7 | JC_iEC_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.23e-04 | 157 | 164 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | NOL4 MAP4 PPM1D WWP2 SYNPO2L BRSK2 DAB1 DRGX FNDC4 RUNX1T1 ST7L DNAJC6 TTLL7 BMP2 LMNA GLRA2 SLAIN1 | 2.34e-04 | 827 | 164 | 17 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_100 | 2.84e-04 | 17 | 164 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | VAPA LIMA1 RBBP6 DAB1 NUP214 SIM1 REV3L MED13L RUNX1T1 DNAJC6 CEP350 USP31 FAM193A NAV3 GIGYF2 CUX1 | 3.15e-04 | 769 | 164 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | NUP214 ERGIC2 SIM1 REV3L PDLIM5 CEP350 IFFO2 FIP1L1 GIGYF2 CUX1 | 3.15e-04 | 339 | 164 | 10 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | VAMP5 CECR2 ITGA9 TTC3 NCAPH ECT2 WWC2 IGF1R FGD5 PLCB4 QSER1 | 3.57e-04 | 410 | 164 | 11 | GSM791122_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#3_top-relative-expression-ranked_500 | 3.74e-04 | 122 | 164 | 6 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | ITCH WWP2 DAB1 NUP214 EPS8L1 NR6A1 ERGIC2 SIM1 REV3L CEP350 CLMN CRB3 FIP1L1 DANCR CUX1 MUC20 | 4.00e-04 | 786 | 164 | 16 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | NOL4 HIVEP2 MAP4 BRSK2 DAB1 FNDC4 TRIOBP EPS8L1 RUNX1T1 DNAJC6 PDLIM5 FAM193A CSF1 LMNA LRIG1 SETD5 NAV3 SLAIN1 CACNG4 C1orf216 FAM149B1 | 4.20e-04 | 1208 | 164 | 21 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | VAMP5 DNAJC6 WWC2 IGF1R NFIC FGD5 PLCB4 QSER1 TNS1 CUX1 TREML2 | 4.64e-04 | 423 | 164 | 11 | GSM399454_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | HIF1A ITCH MAP4 SRP72 NR6A1 RUNX1T1 ARID1A ECT2 BMP2 MAST4 CLMN FIP1L1 ANKRD17 GIGYF2 SPIDR TP53 | 5.12e-04 | 804 | 164 | 16 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | SETD1B MAP4 RBBP6 DAB1 NUP214 ERGIC2 REV3L RUNX1T1 CEP350 USP31 FAM193A SETD5 GIGYF2 ZMYM4 CUX1 PDZD2 | 5.26e-04 | 806 | 164 | 16 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | alpha beta T cells, T.4FP3-.Sp, 4+ 8- GFP- 44lo, Spleen, avg-3 | SPN PPP1R13B ZHX2 PACS1 LRIG1 ARHGEF1 SLAIN1 TP53 TREML2 RASGRP2 | 5.50e-04 | 364 | 164 | 10 | GSM605766_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_200 | 6.04e-04 | 88 | 164 | 5 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | DAB1 NUP214 ERGIC2 REV3L CEP350 USP31 FAM193A SETD5 ZMYM4 CUX1 | 6.12e-04 | 369 | 164 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | MAP4 DRGX TNRC6B NUP214 REV3L RUNX1T1 DNAJC6 CEP350 USP31 FAM193A SETD5 RPTOR GLRA2 PLCB4 ZMYM4 CUX1 | 6.16e-04 | 818 | 164 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 6.19e-04 | 186 | 164 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 6.36e-04 | 89 | 164 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#2_top-relative-expression-ranked_500 | 6.46e-04 | 51 | 164 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | HIVEP2 SH2B3 VAMP5 EVI2B PDLIM5 ARHGEF15 IFNGR1 ECSCR NAV3 FGD5 RASGRP2 | 6.92e-04 | 444 | 164 | 11 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k3_1000 |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | GPHN ATXN7L1 TNRC6B MED13L IGF1R MAST4 ANKRD17 NHS CUX1 PDZD2 | 2.95e-09 | 192 | 166 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-08 | 185 | 166 | 9 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 5.52e-08 | 196 | 166 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.28e-08 | 199 | 166 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.69e-07 | 161 | 166 | 8 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-07 | 187 | 166 | 8 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-07 | 187 | 166 | 8 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-07 | 192 | 166 | 8 | 6806a1a9fe00395dc1abc3e0124b4261dc701f31 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.70e-07 | 193 | 166 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-07 | 196 | 166 | 8 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-07 | 196 | 166 | 8 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.12e-07 | 198 | 166 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.44e-07 | 199 | 166 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.76e-07 | 200 | 166 | 8 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.76e-07 | 200 | 166 | 8 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.76e-07 | 200 | 166 | 8 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 158 | 166 | 7 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.00e-06 | 179 | 166 | 7 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.18e-06 | 180 | 166 | 7 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.57e-06 | 182 | 166 | 7 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.78e-06 | 183 | 166 | 7 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.78e-06 | 183 | 166 | 7 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 185 | 166 | 7 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 187 | 166 | 7 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 187 | 166 | 7 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.13e-06 | 189 | 166 | 7 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-06 | 190 | 166 | 7 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-06 | 190 | 166 | 7 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.64e-06 | 191 | 166 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.18e-06 | 193 | 166 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.46e-06 | 194 | 166 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 194 | 166 | 7 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.74e-06 | 195 | 166 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 9.04e-06 | 196 | 166 | 7 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 196 | 166 | 7 | 97ac47daf5bb07fa5dda3976e1ae402750f959b5 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.35e-06 | 197 | 166 | 7 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.35e-06 | 197 | 166 | 7 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 198 | 166 | 7 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.98e-06 | 199 | 166 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.98e-06 | 199 | 166 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.98e-06 | 199 | 166 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-06 | 199 | 166 | 7 | f35e9c05d0a0339ff691b38564da7aad8e9218aa | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.98e-06 | 199 | 166 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-06 | 199 | 166 | 7 | 33f1669eeb701986b4dec409efdb6c06c3c41c2b | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.03e-05 | 200 | 166 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.03e-05 | 200 | 166 | 7 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 1.17e-05 | 135 | 166 | 6 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 155 | 166 | 6 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.75e-05 | 157 | 166 | 6 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.51e-05 | 164 | 166 | 6 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.01e-05 | 168 | 166 | 6 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 4.01e-05 | 168 | 166 | 6 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.01e-05 | 168 | 166 | 6 | 0e99ecd94ab8e5372e30433d7d0aa76b4d54257a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.01e-05 | 168 | 166 | 6 | 34722e14f28313f2e4644b3c1861ef12958cee9f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 169 | 166 | 6 | f2e20049a17eee533d49bd5f24a51962d123d132 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 169 | 166 | 6 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 169 | 166 | 6 | 4c6892551e9dec94fc62b3beab1e6d424639a1e9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 4.29e-05 | 170 | 166 | 6 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 173 | 166 | 6 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.73e-05 | 173 | 166 | 6 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 4.88e-05 | 174 | 166 | 6 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 177 | 166 | 6 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 177 | 166 | 6 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.54e-05 | 178 | 166 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.54e-05 | 178 | 166 | 6 | c30d3390fc4a7856f50ba8ff6694c0333165ddde | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.54e-05 | 178 | 166 | 6 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.71e-05 | 179 | 166 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 5.71e-05 | 179 | 166 | 6 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.71e-05 | 179 | 166 | 6 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.71e-05 | 179 | 166 | 6 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.89e-05 | 180 | 166 | 6 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 5.89e-05 | 180 | 166 | 6 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.89e-05 | 180 | 166 | 6 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.89e-05 | 180 | 166 | 6 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 181 | 166 | 6 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.26e-05 | 182 | 166 | 6 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.26e-05 | 182 | 166 | 6 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 6.46e-05 | 183 | 166 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-05 | 183 | 166 | 6 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.46e-05 | 183 | 166 | 6 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-05 | 184 | 166 | 6 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.65e-05 | 184 | 166 | 6 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.86e-05 | 185 | 166 | 6 | 3fafb1d36c5f98a29d20a5ce5192c83d6f603514 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.86e-05 | 185 | 166 | 6 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.06e-05 | 186 | 166 | 6 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass | 7.06e-05 | 186 | 166 | 6 | 3314def702fe6a5056d0dadbb3a587c5d1a16412 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 186 | 166 | 6 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 186 | 166 | 6 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 7.06e-05 | 186 | 166 | 6 | 701eea0016d69f0f9d29b613948f91239096e6c7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-05 | 186 | 166 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.06e-05 | 186 | 166 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.28e-05 | 187 | 166 | 6 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.28e-05 | 187 | 166 | 6 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 187 | 166 | 6 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 187 | 166 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 187 | 166 | 6 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-05 | 188 | 166 | 6 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-05 | 188 | 166 | 6 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-05 | 188 | 166 | 6 | 05de6677f9bb4b00fed47f4b72f4a2cd507cb0f2 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-05 | 188 | 166 | 6 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| Computational | Neighborhood of ARAF1 | 9.83e-05 | 78 | 103 | 6 | MORF_ARAF1 | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; HL60; HG-U133A | GPHN SPN MAP4 NUP214 EPS8L1 MAST2 ARHGEF15 LUZP1 DOCK5 WWC2 CACNG4 TNS1 | 2.39e-08 | 197 | 166 | 12 | 1763_UP |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | ONECUT2 ATXN2L INCENP EPS8L1 BCL3 PPFIA3 MAST2 LUZP1 PACS1 MAST4 KCNF1 CACNG4 | 2.53e-08 | 198 | 166 | 12 | 3406_UP |
| Drug | carmustine; Down 200; 100uM; PC3; HT_HG-U133A | ATXN7L1 FNDC4 ST7L ZHX2 DENND2B LUZP1 GAB2 TTLL7 SPIDR MBD4 TNS1 | 1.93e-07 | 194 | 166 | 11 | 6883_DN |
| Drug | Lisinopril [83915-83-7]; Down 200; 9uM; MCF7; HT_HG-U133A | GPHN ATXN2L MAP4 MAST2 GAB2 CACTIN MAP1S PLCB3 CACNG4 SPIDR ZMYM4 | 2.50e-07 | 199 | 166 | 11 | 7403_DN |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; HL60; HT_HG-U133A | HIVEP2 MAST2 PDLIM5 DOCK5 HIVEP3 CACTIN NFIC PLCB3 TNS1 SZRD1 RASGRP2 | 2.50e-07 | 199 | 166 | 11 | 2135_DN |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A | MAP4 BCL3 ARID1A ARHGEF15 GSK3A GAB2 LMNA STRADA UNKL CUX1 SOS1 | 2.63e-07 | 200 | 166 | 11 | 2027_DN |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | HIVEP2 EPS8L1 NR6A1 GSK3A LUZP1 MAST4 LRIG1 QSER1 FAM149B1 MUC5AC | 5.61e-07 | 172 | 166 | 10 | 1017_UP |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | SETD1B ZCCHC8 EPS8L1 BCL3 ARID1A ZHX2 IGF1R FAM193A NFIC PLCB4 | 6.93e-07 | 176 | 166 | 10 | 981_DN |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.53e-06 | 192 | 166 | 10 | 6013_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.76e-06 | 195 | 166 | 10 | 2805_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A | ONECUT2 ATXN2L EPRS1 SPN VAMP5 NUP214 PDLIM5 GSK3A HIVEP3 LMNA | 1.76e-06 | 195 | 166 | 10 | 4508_DN |
| Drug | Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | ONECUT2 INCENP MAP4 DENND2B SH2B1 GSK3A PACS1 CACTIN KCNF1 MAST3 | 1.84e-06 | 196 | 166 | 10 | 2815_UP |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | MAP4 TRIOBP PROSER1 EPS8L1 PPFIA3 MAST2 CACTIN MAST4 CUX1 SOS1 | 1.84e-06 | 196 | 166 | 10 | 5293_DN |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | HIVEP2 SETD1B INCENP SPN EPS8L1 PPFIA3 ARID1A LUZP1 PACS1 LMNA | 1.84e-06 | 196 | 166 | 10 | 1511_DN |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.93e-06 | 197 | 166 | 10 | 6011_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; HL60; HG-U133A | SPN RBBP6 TRIOBP MED13L PDLIM5 CACTIN NSFL1C LMNA CACNG4 SZRD1 | 1.93e-06 | 197 | 166 | 10 | 1394_DN |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; HL60; HG-U133A | SPN ZCCHC8 FNBP4 IGFLR1 NCAPH ARHGEF15 GSK3A IGF1R MAP1S CUX1 | 1.93e-06 | 197 | 166 | 10 | 2040_DN |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A | EXPH5 NUP214 PPFIA3 ARID1A SH2B1 LMNA MAP1S KCNF1 ARHGEF1 PLCB3 | 1.93e-06 | 197 | 166 | 10 | 7197_DN |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | TRIOBP MAST2 PDLIM5 HIVEP3 PACS1 CACTIN CSF1 UNKL PLCB3 MAST3 | 1.93e-06 | 197 | 166 | 10 | 5815_DN |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A | MAP4 EPS8L1 CACTIN WWC2 MAST4 NFIC FIP1L1 FAM149B1 ZMYM4 SOS1 | 2.02e-06 | 198 | 166 | 10 | 6224_DN |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A | SPN VAMP5 NUP214 PDLIM5 PACS1 CACTIN PLEKHG6 NFIC ARHGEF1 TNS1 | 2.02e-06 | 198 | 166 | 10 | 6421_DN |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A | SETD1B NR6A1 PPFIA3 ARID1A GSK3A LMNA ARHGEF1 TNS1 MUC5AC RASGRP2 | 2.11e-06 | 199 | 166 | 10 | 3226_UP |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; PC3; HT_HG-U133A | PPP1R13B EPS8L1 DENND2B GSK3A HIVEP3 CACTIN CSF1 NFIC NAV3 PLCB3 | 2.11e-06 | 199 | 166 | 10 | 5836_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.53e-06 | 170 | 166 | 9 | 1050_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 4.75e-06 | 171 | 166 | 9 | 7535_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.74e-06 | 175 | 166 | 9 | 7236_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.29e-06 | 177 | 166 | 9 | 6434_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 6.59e-06 | 178 | 166 | 9 | 6193_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.59e-06 | 178 | 166 | 9 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.59e-06 | 178 | 166 | 9 | 1672_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 6.89e-06 | 179 | 166 | 9 | 332_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 6.89e-06 | 179 | 166 | 9 | 331_DN | |
| Drug | cellobiitol | 7.00e-06 | 37 | 166 | 5 | CID000003871 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 7.88e-06 | 182 | 166 | 9 | 3887_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 8.99e-06 | 185 | 166 | 9 | 1114_DN | |
| Drug | Asbestos, Crocidolite | LIMA1 HIF1A HIVEP2 RBBP6 PPM1D NR6A1 BCL3 ARID1A LUZP1 HIVEP3 BMP2 IGF1R MAST4 EIF4B NAV3 MAP3K9 NCOA7 NHS GIGYF2 FAM149B1 AFF4 TP53 RASGRP2 SOS1 | 1.19e-05 | 1241 | 166 | 24 | ctd:D017638 |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.26e-05 | 193 | 166 | 9 | 6868_UP | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.37e-05 | 195 | 166 | 9 | 2475_DN | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.37e-05 | 195 | 166 | 9 | 5392_UP | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 1.43e-05 | 196 | 166 | 9 | 6994_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; PC3; HG-U133A | 1.43e-05 | 196 | 166 | 9 | 1904_UP | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.43e-05 | 196 | 166 | 9 | 1516_DN | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; HL60; HG-U133A | 1.49e-05 | 197 | 166 | 9 | 1746_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 6941_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; HL60; HG-U133A | 1.49e-05 | 197 | 166 | 9 | 1551_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 3439_DN | |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 1545_DN | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; HL60; HG-U133A | 1.49e-05 | 197 | 166 | 9 | 1392_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; HL60; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 3056_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; HL60; HG-U133A | 1.49e-05 | 197 | 166 | 9 | 1388_UP | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 1810_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 3433_DN | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 2751_UP | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 3865_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.49e-05 | 197 | 166 | 9 | 6360_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 2288_UP | |
| Drug | iloprost; Up 200; 1uM; MCF7; HG-U133A | 1.55e-05 | 198 | 166 | 9 | 488_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 6200_UP | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 7189_DN | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 4805_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 2124_UP | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 3576_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.55e-05 | 198 | 166 | 9 | 6001_DN | |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; HL60; HG-U133A | 1.55e-05 | 198 | 166 | 9 | 1766_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A | MAP4 TNRC6B NUP214 PPFIA3 MAST2 PDLIM5 GAB2 EIF4ENIF1 CACNG4 | 1.61e-05 | 199 | 166 | 9 | 7009_DN |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.61e-05 | 199 | 166 | 9 | 5997_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HG-U133A | 1.61e-05 | 199 | 166 | 9 | 348_DN | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.61e-05 | 199 | 166 | 9 | 3618_UP | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.61e-05 | 199 | 166 | 9 | 2744_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A | 1.68e-05 | 200 | 166 | 9 | 665_DN | |
| Drug | AC1NSJX8 | 3.10e-05 | 9 | 166 | 3 | CID005311059 | |
| Drug | 2,4,4'-trichlorobiphenyl | NOL4 HIF1A ZEB1 INCENP ICE2 CECR2 FNBP4 DAB1 TRIOBP PPFIA3 ARID1A TTC3 NCAPH DNAJC6 ECT2 ARHGEF15 TTLL7 SPATC1 USP31 PLEKHG6 CRB3 PLCB4 IGSF9B QSER1 TP53 | 3.35e-05 | 1411 | 166 | 25 | ctd:C081766 |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.63e-05 | 170 | 166 | 8 | 7043_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.63e-05 | 170 | 166 | 8 | 5260_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.95e-05 | 172 | 166 | 8 | 1072_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 4.28e-05 | 174 | 166 | 8 | 7530_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.46e-05 | 175 | 166 | 8 | 1058_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.64e-05 | 176 | 166 | 8 | 6932_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.64e-05 | 176 | 166 | 8 | 2639_DN | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | NOL4 HIF1A ZEB1 INCENP ICE2 CECR2 FNBP4 DAB1 TRIOBP PPFIA3 ARID1A TTC3 NCAPH DNAJC6 ECT2 ARHGEF15 TTLL7 SPATC1 USP31 PLEKHG6 CRB3 PLCB4 IGSF9B QSER1 TP53 | 4.73e-05 | 1441 | 166 | 25 | ctd:C009828 |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.83e-05 | 177 | 166 | 8 | 985_DN | |
| Drug | nocodazole | GPHN INCENP MAP4 RBBP6 ZCCHC8 SIM1 ECT2 GSK3A CEP350 DOCK5 LMNA MAP1S TP53 | 5.01e-05 | 477 | 166 | 13 | CID000004122 |
| Drug | SA-8 | 5.28e-05 | 2 | 166 | 2 | CID000199094 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.44e-05 | 180 | 166 | 8 | 5511_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.44e-05 | 180 | 166 | 8 | 6454_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.44e-05 | 180 | 166 | 8 | 4541_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.12e-05 | 183 | 166 | 8 | 1709_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 6.12e-05 | 183 | 166 | 8 | 7498_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.12e-05 | 183 | 166 | 8 | 5613_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 6.60e-05 | 185 | 166 | 8 | 6286_UP | |
| Drug | Isotretinoin [4759-48-2]; Down 200; 13.4uM; HL60; HT_HG-U133A | 6.86e-05 | 186 | 166 | 8 | 2407_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A | 7.12e-05 | 187 | 166 | 8 | 6190_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 7.12e-05 | 187 | 166 | 8 | 5958_UP | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 7.39e-05 | 188 | 166 | 8 | 1218_DN | |
| Drug | Clodronic Acid | 7.67e-05 | 243 | 166 | 9 | ctd:D004002 | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 8.25e-05 | 191 | 166 | 8 | 4279_DN | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; PC3; HT_HG-U133A | 8.25e-05 | 191 | 166 | 8 | 4471_DN | |
| Drug | rioprostil | 8.36e-05 | 32 | 166 | 4 | CID005311413 | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 8.56e-05 | 192 | 166 | 8 | 7004_UP | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 8.56e-05 | 192 | 166 | 8 | 1661_DN | |
| Disease | Neurodevelopmental Disorders | 9.52e-07 | 93 | 165 | 7 | C1535926 | |
| Disease | Malignant neoplasm of breast | HIF1A ZEB1 PPM1D NUP214 SIM1 MAGEE1 ITGA9 ARID1A TTC3 ECT2 BMP2 IGF1R CSF1 NHS BOD1L1 FGD5 TNS1 CUX1 TP53 | 9.81e-06 | 1074 | 165 | 19 | C0006142 |
| Disease | body surface area | VAMP5 SIM1 MED13L ZHX2 LUZP1 DOCK5 WWC2 IGF1R SETD5 NFIC RPTOR NCOA7 GIGYF2 TP53 | 1.67e-05 | 643 | 165 | 14 | EFO_0022196 |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 2.00e-05 | 10 | 165 | 3 | EFO_1000650, HP_0000131 | |
| Disease | creatinine measurement | HIF1A ICE2 WBP1L TNRC6B SIM1 ARID1A MAST2 PDLIM5 GAB2 IGF1R LRIG1 EIF4B FIP1L1 NCOA7 GIGYF2 MBD4 CUX1 | 4.57e-05 | 995 | 165 | 17 | EFO_0004518 |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 4.71e-05 | 13 | 165 | 3 | DOID:0050787 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | ATXN2L ITCH BRSK2 DAB1 TRIOBP TNRC6B MED13L RUNX1T1 ST7L MAST2 LUZP1 BMP2 MAST4 LRIG1 NAV3 QSER1 TNS1 CUX1 PDZD2 SOS1 | 6.67e-05 | 1345 | 165 | 20 | EFO_0010736 |
| Disease | reticulocyte count | EPRS1 SH2B3 VAMP5 ZCCHC8 TNRC6B ZHX2 MAST2 DENND2B DOCK5 KCNU1 NFIC NCOA7 PLCB3 TNS1 CUX1 TREML2 PDZD2 | 8.33e-05 | 1045 | 165 | 17 | EFO_0007986 |
| Disease | keratoconjunctivitis (is_marker_for) | 9.29e-05 | 3 | 165 | 2 | DOID:9368 (is_marker_for) | |
| Disease | neuroimaging measurement | ATXN2L ITCH BRSK2 DAB1 TNRC6B REV3L RUNX1T1 ST7L ZHX2 LUZP1 BMP2 MAST4 ARHGEF1 NAV3 QSER1 TNS1 SZRD1 | 1.09e-04 | 1069 | 165 | 17 | EFO_0004346 |
| Disease | uterine fibroid | 1.35e-04 | 199 | 165 | 7 | EFO_0000731 | |
| Disease | ascending aortic diameter | 1.41e-04 | 140 | 165 | 6 | EFO_0021787 | |
| Disease | Uterine leiomyoma | 1.62e-04 | 91 | 165 | 5 | HP_0000131 | |
| Disease | electrocardiography | ATXN2L SYNPO2L DAB1 PDLIM5 LUZP1 IGF1R MAST4 LRIG1 EIF4B NCOA7 MYO18B | 2.08e-04 | 530 | 165 | 11 | EFO_0004327 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.22e-04 | 364 | 165 | 9 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Granulomatous Slack Skin | 2.45e-04 | 22 | 165 | 3 | C0376407 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 2.80e-04 | 23 | 165 | 3 | C0079773 | |
| Disease | brain measurement, neuroimaging measurement | ATXN2L BRSK2 DAB1 TRIOBP RUNX1T1 ST7L LUZP1 MAST4 ARHGEF1 NAV3 TNS1 | 2.85e-04 | 550 | 165 | 11 | EFO_0004346, EFO_0004464 |
| Disease | reticulocyte measurement | VAPA GPHN SH2B3 VAMP5 ZCCHC8 TNRC6B DENND2B ARHGEF15 GAB2 DOCK5 PACS1 NCOA7 PLCB3 TNS1 CUX1 PDZD2 | 2.92e-04 | 1053 | 165 | 16 | EFO_0010700 |
| Disease | vesicoureteral reflux (is_marker_for) | 3.07e-04 | 5 | 165 | 2 | DOID:9620 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.84e-04 | 61 | 165 | 4 | DOID:3587 (is_marker_for) | |
| Disease | Alzheimer disease | 4.25e-04 | 485 | 165 | 10 | MONDO_0004975 | |
| Disease | body fat percentage | PDS5B ATXN2L ZCCHC8 SIM1 HIVEP3 PACS1 KCNU1 LRIG1 RPTOR IGSF9B | 4.46e-04 | 488 | 165 | 10 | EFO_0007800 |
| Disease | Sezary Syndrome | 4.55e-04 | 27 | 165 | 3 | C0036920 | |
| Disease | chronotype measurement | NOL4 RBBP6 ZCCHC8 BRSK2 FNBP4 TNRC6B MED13L RUNX1T1 USP31 FAM193A KCNF1 NAV3 PLCB4 CUX1 | 4.59e-04 | 882 | 165 | 14 | EFO_0008328 |
| Disease | cholangiocarcinoma (is_marker_for) | 4.61e-04 | 64 | 165 | 4 | DOID:4947 (is_marker_for) | |
| Disease | aortic measurement | 5.51e-04 | 251 | 165 | 7 | EFO_0020865 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 6.24e-04 | 30 | 165 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | Developmental regression | 6.41e-04 | 7 | 165 | 2 | C1836830 | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 6.41e-04 | 7 | 165 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | eosinophil count | LIMA1 HIVEP2 SH2B3 ATXN7L1 ICE2 WWP2 BCL3 NCAPH KANSL3 SPATC1 HIVEP3 FAM193A NFIC PLCB3 SPIDR MUC5AC CUX1 TP53 MAST3 | 6.87e-04 | 1488 | 165 | 19 | EFO_0004842 |
| Disease | retinal vasculature measurement | 6.95e-04 | 517 | 165 | 10 | EFO_0010554 | |
| Disease | Endometrial Carcinoma | 7.21e-04 | 72 | 165 | 4 | C0476089 | |
| Disease | Squamous cell carcinoma of lung | 7.56e-04 | 32 | 165 | 3 | C0149782 | |
| Disease | grip strength measurement | 8.28e-04 | 350 | 165 | 8 | EFO_0006941 | |
| Disease | myocardial infarction | 8.28e-04 | 350 | 165 | 8 | EFO_0000612 | |
| Disease | colorectal adenoma | 8.28e-04 | 33 | 165 | 3 | EFO_0005406 | |
| Disease | QT interval | ATXN2L SYNPO2L MAST2 SH2B1 PDLIM5 DOCK5 NFIC NCOA7 ANAPC7 CUX1 | 8.89e-04 | 534 | 165 | 10 | EFO_0004682 |
| Disease | Breast Carcinoma | 9.41e-04 | 538 | 165 | 10 | C0678222 | |
| Disease | Erythrocytosis familial, 1 | 1.09e-03 | 9 | 165 | 2 | C4551637 | |
| Disease | coronary artery disease | PDS5B ZEB1 HIVEP2 SH2B3 VAMP5 WBP1L DAB1 DENND2B PDLIM5 DOCK5 MAST4 MAP1S RPTOR GIGYF2 FGD5 TNS1 | 1.12e-03 | 1194 | 165 | 16 | EFO_0001645 |
| Disease | serum alanine aminotransferase measurement | PDS5B ATXN2L ITCH SH2B3 ZCCHC8 EXPH5 WWP2 FNBP4 ARID1A ATP10D GAB2 STRADA MAST3 | 1.25e-03 | 869 | 165 | 13 | EFO_0004735 |
| Disease | neuroblastoma (is_implicated_in) | 1.36e-03 | 10 | 165 | 2 | DOID:769 (is_implicated_in) | |
| Disease | dry eye syndrome (is_marker_for) | 1.36e-03 | 10 | 165 | 2 | DOID:10140 (is_marker_for) | |
| Disease | QRS duration | 1.49e-03 | 298 | 165 | 7 | EFO_0005055 | |
| Disease | cortical thickness | PDS5B DAB1 TRIOBP TNRC6B RUNX1T1 MAST2 LUZP1 BMP2 IGF1R MAST4 SETD5 NAV3 QSER1 TNS1 PDZD2 | 1.52e-03 | 1113 | 165 | 15 | EFO_0004840 |
| Disease | prostate carcinoma | INCENP EXPH5 PPP1R13B TNRC6B MAST2 PDLIM5 CEP350 IGF1R MAST4 LMNA QSER1 TP53 SOS1 | 1.57e-03 | 891 | 165 | 13 | EFO_0001663 |
| Disease | gait measurement | 1.59e-03 | 150 | 165 | 5 | EFO_0007680 | |
| Disease | Ductal Carcinoma | 1.65e-03 | 11 | 165 | 2 | C1176475 | |
| Disease | pulmonary fibrosis | 1.65e-03 | 11 | 165 | 2 | EFO_0009448 | |
| Disease | hematocrit | HIVEP2 SH2B3 WBP1L PPP1R13B TNRC6B SIM1 MAST2 DENND2B ARHGEF15 STRADA ANKRD17 NCOA7 PLCB3 FGD5 | 1.69e-03 | 1011 | 165 | 14 | EFO_0004348 |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 1.80e-03 | 43 | 165 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | serum gamma-glutamyl transferase measurement | ZEB1 ICE2 TRIOBP ITGA9 ARID1A DENND2B ARHGEF15 WWC2 IGF1R POM121 MAP1S SIPA1L2 MAST3 | 1.96e-03 | 914 | 165 | 13 | EFO_0004532 |
| Disease | age at menarche | 1.96e-03 | 594 | 165 | 10 | EFO_0004703 | |
| Disease | bronchopulmonary dysplasia (biomarker_via_orthology) | 1.98e-03 | 12 | 165 | 2 | DOID:11650 (biomarker_via_orthology) | |
| Disease | outer ear morphology trait | 1.98e-03 | 12 | 165 | 2 | EFO_0007664 | |
| Disease | Thrombocythemia, Essential | 1.98e-03 | 12 | 165 | 2 | C0040028 | |
| Disease | pulse pressure measurement | WWP2 WBP1L SYNPO2L TRIOBP TNRC6B MED13L ITGA9 MAST2 PDLIM5 LUZP1 HIVEP3 FAM193A LRIG1 RPTOR FGD5 TP53 PHF13 | 2.12e-03 | 1392 | 165 | 17 | EFO_0005763 |
| Disease | Cardiotoxicity | 2.33e-03 | 13 | 165 | 2 | C0876994 | |
| Disease | skin melanoma (is_marker_for) | 2.33e-03 | 13 | 165 | 2 | DOID:8923 (is_marker_for) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.35e-03 | 99 | 165 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | comparative body size at age 10, self-reported | 2.60e-03 | 420 | 165 | 8 | EFO_0009819 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.62e-03 | 102 | 165 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 2.62e-03 | 49 | 165 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | fetal genotype effect measurement, body weights and measures | 2.62e-03 | 49 | 165 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.67e-03 | 169 | 165 | 5 | DOID:3908 (is_marker_for) | |
| Disease | C-X-C motif chemokine 11 measurement | 2.71e-03 | 14 | 165 | 2 | EFO_0008057 | |
| Disease | Adenocarcinoma Of Esophagus | 2.71e-03 | 14 | 165 | 2 | C0279628 | |
| Disease | melanoma | 2.79e-03 | 248 | 165 | 6 | C0025202 | |
| Disease | JT interval | 2.79e-03 | 248 | 165 | 6 | EFO_0007885 | |
| Disease | Mammary Carcinoma, Human | 2.90e-03 | 525 | 165 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.90e-03 | 525 | 165 | 9 | C1257931 | |
| Disease | Leukemia, Myelocytic, Acute | 2.95e-03 | 173 | 165 | 5 | C0023467 | |
| Disease | Mammary Neoplasms | 2.97e-03 | 527 | 165 | 9 | C1458155 | |
| Disease | eosinophil percentage of leukocytes | HIVEP2 ATXN7L1 ICE2 BCL3 NCAPH KANSL3 HIVEP3 FAM193A MUC5AC CUX1 MAST3 | 3.29e-03 | 746 | 165 | 11 | EFO_0007991 |
| Disease | plasminogen activator inhibitor 1 measurement | 3.46e-03 | 54 | 165 | 3 | EFO_0004792 | |
| Disease | left ventricular diastolic function measurement | 3.46e-03 | 54 | 165 | 3 | EFO_0008204 | |
| Disease | Small cell carcinoma of lung | 3.46e-03 | 54 | 165 | 3 | C0149925 | |
| Disease | Unipolar Depression | 3.46e-03 | 259 | 165 | 6 | C0041696 | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 3.54e-03 | 16 | 165 | 2 | DOID:10964 (is_marker_for) | |
| Disease | T-Cell Lymphoma | 3.54e-03 | 16 | 165 | 2 | C0079772 | |
| Disease | response to acetylsalicylate | 3.54e-03 | 16 | 165 | 2 | GO_1903492 | |
| Disease | diffuse plaque measurement | ONECUT2 RBBP6 CECR2 DNAJC6 BMP2 SCAF1 MAST4 NAV3 SLAIN1 CACNG4 TNS1 | 3.71e-03 | 758 | 165 | 11 | EFO_0010699 |
| Disease | waist-hip ratio | ATXN7L1 WWP2 TNRC6B SIM1 ITGA9 SH2B1 BMP2 HAUS8 IGF1R MAST4 NAV3 PLCB3 MINDY4 ZMYM4 CUX1 | 3.79e-03 | 1226 | 165 | 15 | EFO_0004343 |
| Disease | Alzheimer's disease (implicated_via_orthology) | 4.03e-03 | 57 | 165 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Endometrial Neoplasms | 4.23e-03 | 58 | 165 | 3 | C0014170 | |
| Disease | Malignant neoplasm of skin | 4.44e-03 | 59 | 165 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 4.44e-03 | 59 | 165 | 3 | C0037286 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 4.48e-03 | 18 | 165 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Adrenocortical carcinoma | 4.48e-03 | 18 | 165 | 2 | C0206686 | |
| Disease | diastolic blood pressure, systolic blood pressure | TNRC6B DENND2B PDLIM5 CEP350 DOCK5 CSF1 LRIG1 FIP1L1 CUX1 TP53 | 4.60e-03 | 670 | 165 | 10 | EFO_0006335, EFO_0006336 |
| Disease | urate measurement | NOL4 MAP4 ARID1A IGF1R LMNA NFIC NCOA7 PLCB3 MINDY4 MYO18B MAST3 RASGRP2 | 4.64e-03 | 895 | 165 | 12 | EFO_0004531 |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 4.87e-03 | 61 | 165 | 3 | C1961102 | |
| Disease | Brugada syndrome | 4.99e-03 | 19 | 165 | 2 | MONDO_0015263 | |
| Disease | cerebral infarction (is_marker_for) | 4.99e-03 | 19 | 165 | 2 | DOID:3526 (is_marker_for) | |
| Disease | Usual Interstitial Pneumonia | 4.99e-03 | 19 | 165 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 4.99e-03 | 19 | 165 | 2 | C4721508 | |
| Disease | aspartate aminotransferase measurement | ONECUT2 SH2B3 EVI2B NUP214 ST7L ITGA9 GAB2 TTLL7 WWC2 CSF1 TP53 SOS1 | 5.01e-03 | 904 | 165 | 12 | EFO_0004736 |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 5.53e-03 | 20 | 165 | 2 | C4721952 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STASFRDNVTSPLPS | 216 | Q9P0L0 | |
| SGTNTSSPRISPATT | 371 | Q8IVW6 | |
| SNLSSEASARPSGTQ | 96 | Q8TF63 | |
| SPSSTREPLLSSSEN | 776 | Q92888 | |
| SLTGASRSETPQNSP | 896 | P39880 | |
| STSTALPPREDDSSQ | 151 | Q96RQ1 | |
| SSLSIDSRSSSPEPA | 116 | Q8TAB5 | |
| LPPSASRASLDSQTS | 76 | O94989 | |
| SRASLDSQTSPDSPS | 81 | O94989 | |
| ETTNTRPPNSSSSSG | 2086 | O75179 | |
| LPSSPSSLNEDSLST | 586 | P78524 | |
| ASSGRPSSQPSDEVL | 36 | P12643 | |
| SSSSTQPPREVGTSN | 611 | Q9BXF3 | |
| LAERSPPSVSSASSG | 251 | P78312 | |
| GTQPQPTLSSRSSSL | 106 | P0C864 | |
| RVNGTSSPQSPLSTS | 326 | Q96KQ4 | |
| SSPQSPLSTSGRVAA | 331 | Q96KQ4 | |
| SSPSSISSPGHSRQN | 836 | Q9ULK2 | |
| RSSSPSLNSGKEPSS | 636 | Q9P241 | |
| TLSSPSNRPSGETSV | 421 | Q8WWM7 | |
| VGPAPSTSQSQKRSS | 111 | Q9UHB7 | |
| PSGLLSPNQTVSSSA | 516 | Q6IQ32 | |
| FTATPSSSPGTARTL | 2616 | Q9HC84 | |
| SNASSSSNPSSPGRI | 1156 | Q9NTI5 | |
| SSASRAQNLPDSSPT | 476 | Q2KHR3 | |
| SRLSSTSSLAGIPSP | 876 | Q9H8V3 | |
| AQRLSSGDPSTSPSL | 251 | Q99504 | |
| ASLSTTPSESPRAQA | 261 | Q9NQX3 | |
| SRSSSPTLTPSQEGS | 321 | P0C860 | |
| SLQSRPSSLPDLSGS | 631 | O14497 | |
| KVRPSTGNSASTPQS | 81 | Q9UJX3 | |
| ASSSPSLFSSDRPQV | 2401 | Q8WXI7 | |
| SLFSSDRPQVPTSTT | 2406 | Q8WXI7 | |
| TLDTSSQPGRTSSSP | 10381 | Q8WXI7 | |
| TDSQPATPGASSSRL | 236 | P13349 | |
| RSGAQASSTPLSPTR | 11 | P02545 | |
| SDRSSILSPPFSAGS | 756 | Q9P2G4 | |
| APASPGSSNDSSARS | 756 | Q66K74 | |
| STDQGSPASTPSTTR | 1076 | Q71F56 | |
| AASEGRNTSRPPTSS | 131 | Q9HCI5 | |
| VASTGPSSRSPSTLL | 816 | P27816 | |
| LQPASSLTSGSPERA | 1036 | Q96JA1 | |
| LSPDSRASSLSESSP | 361 | Q9UHB6 | |
| RAQSVSLEGSAPSPS | 551 | Q7LDG7 | |
| LPDNFSTPTGSRTDS | 286 | Q9NQS7 | |
| TTNSPETSSRTSGAP | 136 | P16150 | |
| PPTTTNSSRGTNSTL | 611 | Q8N307 | |
| PRTSSFTPTTLTNGT | 66 | Q06455 | |
| SAVTNRSDLGPPASS | 376 | Q86UE6 | |
| DQTPSPSDGSTRQSS | 496 | Q16665 | |
| SPSAPASSRTSTGNV | 906 | O75145 | |
| ASSGLSTSPLSSPRV | 416 | Q8IWQ3 | |
| PSIPLDVLSASNSSS | 611 | P08069 | |
| GPTFTSTENTPTRSL | 886 | Q02505 | |
| SRQNPPETSSKGSDS | 2426 | O15018 | |
| PSPSTTLARQGSLES | 1276 | Q8IVL0 | |
| NSPRSTPGFILDTTS | 176 | P34910 | |
| SQRNHLPSSGTSTPS | 596 | Q6ZNL6 | |
| TGLPPSRNSTSSQSQ | 266 | Q6UN15 | |
| SRERPPSSSSGSQVA | 311 | O95948 | |
| TEAPASPRGSSSASL | 431 | Q86UT5 | |
| RENSTSSGPSPRDSL | 921 | Q5T7B8 | |
| SRSSSLTLPSSRDPQ | 46 | A0A1B0GTW7 | |
| SSSRPVAPSGTALST | 1291 | P35658 | |
| SINSSNSGPSSLPAL | 1416 | Q8NEV8 | |
| QDSPPRVSASTSSIS | 651 | A8MYU2 | |
| APSSTPGTVSLSTAR | 1881 | P98088 | |
| LSTARTTPAPGTATS | 1891 | P98088 | |
| PGSTKRALPNNTSSS | 301 | P04637 | |
| EPSPQLASSVASTRS | 311 | Q96HC4 | |
| SRSSGAQPASLPTTS | 556 | O15297 | |
| ATPSSVSRGTAPSDN | 56 | Q9UNZ2 | |
| SSSSQAEVPPSLSRS | 391 | Q9BT25 | |
| SPPSSSGLSRDATAT | 781 | Q6VY07 | |
| SLTSNQSSLAPPVSG | 386 | Q7Z6E9 | |
| LSTPLNGSNPLSSIS | 666 | Q86XN7 | |
| IISSTLSSPSSNAPD | 291 | Q96HA1 | |
| SPASTSLSSPGQRDD | 926 | Q01970 | |
| RPSTPSLEGSQSSAE | 541 | Q3KR16 | |
| PGSSVSISFPNRLSS | 821 | Q13797 | |
| RPASVNGSPSATSES | 266 | Q96J02 | |
| ANTLSTPSGSSLQRP | 1091 | Q8NFC6 | |
| GSNLSSRPASPNSSS | 596 | Q659A1 | |
| SRPASPNSSSGQASV | 601 | Q659A1 | |
| RSPAGTTTLTPSSQA | 446 | P49840 | |
| STSSNSSDNAPSRPG | 1681 | Q9H7D0 | |
| SSLRPQGLSNPSTLS | 406 | P09603 | |
| ATVPGTSDSTRSSPQ | 421 | O75553 | |
| ASEETPQTSSSSARP | 366 | Q6Y7W6 | |
| SSRSTEASPSRDVSP | 246 | Q9UBN1 | |
| SDRLPSNSSSPGDIT | 141 | Q9H6D8 | |
| PSSEANRPSHLSSTG | 56 | Q19T08 | |
| GAPSSQERSSPASSI | 131 | Q9H665 | |
| NTSSASSDPFLQPTR | 601 | O75061 | |
| RGTSTSRPLNATATP | 1086 | Q5VT06 | |
| RSSSGSSRQESPSVP | 1541 | Q5VT06 | |
| LRLPGSSDSPASASQ | 176 | Q8TDM0 | |
| LQSANLLPSTSSSPG | 221 | A6NNA5 | |
| SSGDAPEPSSRRTQS | 981 | Q86V48 | |
| PPSSSSELQESRGLS | 191 | O95243 | |
| ADRNSPSPSSVASSD | 481 | Q5TF58 | |
| DSRSGKQPSQTLSPS | 31 | P23416 | |
| SNPSSRDSSPSRDFL | 1081 | Q6P0Q8 | |
| SSNPSSRDSSPSRDP | 926 | O60307 | |
| PSATGQSSFRSTALP | 2441 | O15021 | |
| IASSGPSSSVFPTSR | 276 | Q9P2N6 | |
| SSSASPGRSQSPRAA | 116 | Q8WUQ7 | |
| SSTTNAPGRPSALTL | 281 | Q9NQR7 | |
| TSSNADSASPDLGPR | 231 | Q8TE68 | |
| QDQSRSLSSTPFSSP | 381 | Q9C0E4 | |
| SNGLLSASPSSSPSQ | 391 | P20749 | |
| PGLSDTSPDLSSRSS | 26 | Q9UHW9 | |
| SRELPSATPNTAGSS | 121 | Q9BUN1 | |
| SQAPSSRPISDPSSL | 56 | Q8N4L8 | |
| PSSTSSSSDGNLRPE | 41 | Q9BUF7 | |
| LLASRSPSSNGLSPS | 926 | P80192 | |
| RESSSPLSSNQSEPG | 376 | P15260 | |
| RSPCLSSTSPENITS | 431 | A6NGG8 | |
| KRSSNPPARSQSSDT | 486 | P23588 | |
| DSLSSPSPTPLSRNN | 456 | Q96BN6 | |
| ESNQPSPGSTLSSSR | 186 | Q15406 | |
| HGPRSSPAELSSSSQ | 136 | Q9UQC2 | |
| STPRSSGPVTATSSL | 536 | Q9H987 | |
| PTSNGVVSSPNSTSR | 66 | Q7Z422 | |
| GLSDRPSASISPSSA | 441 | Q9NRF2 | |
| SGLSDSLTTSTPRPS | 321 | Q7RTN6 | |
| QSSDSSPTRNSEPAG | 881 | P07814 | |
| VTASPSNARDSSAGP | 211 | Q5T2D2 | |
| TPQSSSELRPTTTAA | 886 | Q15147 | |
| SSPRSDISQPASQDG | 431 | Q8N3X1 | |
| SESRATTPSLPSVDN | 991 | Q6T4R5 | |
| NSPSSTLRLSSSSPG | 161 | Q8NI08 | |
| TLRLSSSSPGATVSP | 166 | Q8NI08 | |
| SPSNGSSFSLPTNLT | 486 | Q9Y289 | |
| TSRGSPLSPQSSIDS | 236 | Q8ND83 | |
| GTRSSPSNQSSSSDP | 1116 | Q9P2F8 | |
| SPTALSRISSPNSDR | 651 | P81133 | |
| STSFPQNSRSSLPSD | 1371 | Q9C0A6 | |
| SSSQLSPLAPFGTNS | 536 | Q9UPS6 | |
| PRPGSAATVSASTSN | 626 | O76094 | |
| NPASTGLRRTLPSTS | 261 | P08651 | |
| NSPSPQDSPRLSSFT | 336 | P08651 | |
| SETESTASAPNSPRT | 1071 | Q07889 | |
| SSSSSNSRPQLSPTE | 591 | O94818 | |
| SDGPRTSSPSRSKQS | 916 | Q9H2D6 | |
| LDTSSLTQSAPASPT | 851 | Q8N122 | |
| RGNSSSPAPAASITS | 676 | Q9NRA8 | |
| NLSRNSPSSSLSPGS | 146 | Q96JQ2 | |
| QFSTDSPRLLASPSS | 76 | Q15003 | |
| LRSSPSPANSTAGTI | 51 | Q86YI8 | |
| SQLPSRDSSGTAVAP | 161 | O00308 | |
| TPSDSPQTRTASGAV | 496 | Q6NZY4 | |
| LSSRSSLSSLSPPGS | 546 | Q6AWC2 | |
| RSSPSSSSTQPQEES | 231 | Q4G0A6 | |
| GFLSERSTSPINSSP | 1111 | O60673 | |
| PRSTSSPSQSKNGSF | 1856 | O60673 | |
| LSPLTQSPLSSRTGS | 1201 | Q9UPX0 | |
| QSPLSSRTGSPELAA | 1206 | Q9UPX0 | |
| LGSPATSSSQSVAPR | 321 | Q14159 | |
| LSTLLSGPAPTSQSS | 121 | Q76KD6 | |
| RTSSSPASVNDSRGP | 391 | Q76KD6 | |
| TGKTVSPQSNSSRPT | 156 | Q9H7N4 | |
| ASPLSSQPLSGSSRQ | 741 | Q9HBL0 | |
| PPRASLTGTSSTASL | 376 | Q9UF83 | |
| SFESSVPLSRSPSQE | 921 | Q5T1R4 | |
| SATPVTRSSQGSPSV | 1916 | P53804 | |
| VFLPQSSDSSSAPRT | 91 | O95183 | |
| SALEPSTSSSPRGST | 321 | Q9UQQ2 | |
| TESSISEPGSPSRNR | 126 | Q8TDW4 | |
| SSASTSPLGSLSQPL | 476 | Q9H9P5 | |
| LEPASSPLASRSTNT | 2221 | Q8IUG5 | |
| STPSPSPLNLSSSRN | 701 | P37275 | |
| QLSGAQLTSSLPSPS | 616 | Q9Y6X8 | |
| DRASATSTSKPNSPR | 1166 | Q70CQ4 | |
| PSSSRDPSTLENSSA | 456 | Q6UX68 | |
| DSSPLIRSNSVPTSS | 536 | P31629 | |
| IISSTLSSPSSNAPD | 26 | Q6PJE2 | |
| AQSSPLSEPSRSSTR | 156 | Q9NX94 | |
| EQASSSPRSDPLGST | 1236 | Q5VZL5 | |
| RSISAQSPSSGDTRP | 606 | Q6ZT98 | |
| TTGSNSSLNTSLPSP | 1526 | Q9UPQ9 | |
| ERSLPEPGSQSSAAS | 6 | Q9H3M0 | |
| TTAFPDSTTTPGLSR | 1006 | Q9UKN1 | |
| TATTPSPARSTTSGL | 3451 | Q9UKN1 | |
| TTAFPDSTTTPGLSR | 3646 | Q9UKN1 |